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A B S T R A C T
Background
Various methods of conscious sedation and analgesia (CSA) have been used during oocyte retrieval for assisted reproduction. The choice
of agent has been influenced by the quality of sedation and analgesia and by concerns about possible detrimental effects on reproductive
outcomes.
Objectives
To assess the effectiveness and safety of different methods of conscious sedation and analgesia for pain relief and pregnancy outcomes
in women undergoing transvaginal oocyte retrieval.
Search methods
We searched; the Cochrane Gynaecology and Fertility specialised register, CENTRAL, MEDLINE, Embase, PsycINFO and CINAHL,
and trials registers in November 2017. We also checked references, and contacted study authors for additional studies.
Selection criteria
We included randomised controlled trials (RCTs) comparing different methods and administrative protocols for conscious sedation
and analgesia during oocyte retrieval.
Data collection and analysis
We used standard methodological procedures expected by Cochrane. Our primary outcomes were intraoperative and postoperative
pain. Secondary outcomes included clinical pregnancy, patient satisfaction, analgesic side effects, and postoperative complications.
Main results
We included 24 RCTs (3160 women) in five comparisons. We report the main comparisons below. Evidence quality was generally low
or very low, mainly owing to poor reporting and imprecision.
1. CSA versus other active interventions.
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All evidence for this comparison was of very low quality.
CSA versus CSA plus acupuncture or electroacupuncture
Data showmore effective intraoperative pain relief on a 0 to 10 visual analogue scale (VAS) with CSA plus acupuncture (mean difference
(MD) 1.00, 95% confidence interval (CI) 0.18 to 1.82, 62 women) or electroacupuncture (MD 3.00, 95% CI 2.23 to 3.77, 62
women).
Data also show more effective postoperative pain relief (0 to 10 VAS) with CSA plus acupuncture (MD 0.60, 95% CI -0.10 to 1.30,
61 women) or electroacupuncture (MD 2.10, 95% CI 1.40 to 2.80, 61 women).
Evidence was insufficient to show whether clinical pregnancy rates were different between CSA and CSA plus acupuncture (odds ratio
(OR) 0.61, 95% CI 0.20 to 1.86, 61 women). CSA alone may be associated with fewer pregnancies than CSA plus electroacupuncture
(OR 0.22, 95% CI 0.07 to 0.66, 61 women).
Evidence was insufficient to show whether rates of vomiting were different between CSA and CSA plus acupuncture (OR 1.64, 95%
CI 0.46 to 5.88, 62 women) or electroacupuncture (OR 1.09, 95% CI 0.33 to 3.58, 62 women).
Trialists provided no usable data for other outcomes of interest.
CSA versus general anaesthesia
Postoperative pain relief was greater in the CSA group (0 to 3 Likert: mean difference (MD) 1.9, 95% CI 2.24 to 1.56, one RCT, 50
women).
Evidence was insufficient to show whether groups differed in clinical pregnancy rates (OR 1.00, 95% CI 0.43 to 2.35, two RCTs, 108
women, I2 = 0%).
Evidence was insufficient to show whether groups differed in rates of vomiting (OR 0.46, 95% CI 0.08 to 2.75, one RCT, 50 women)
or airway obstruction (OR 0.14, 95% CI 0.02 to 1.22, one RCT, 58 women). Fewer women needed mask ventilation in the CSA
group (OR 0.05, 95% CI 0.01 to 0.20, one RCT, 58 women).
Evidence was also insufficient to show whether groups differed in satisfaction rates (OR 0.66, 95% CI 0.11 to 4.04, two RCTs, 108
women, I2 = 34%; very low-quality evidence).
Trialists provided no usable data for outcomes of interest.
2. CSA + paracervical block (PCB) versus other interventions.
CSA + PCB versus electroacupuncture + PCB
Intraoperative pain scores were lower in the CSA + PCB group (0 to 10 VAS: MD -0.66, 95% CI -0.93 to -0.39, 781 women, I2 =
76%; low-quality evidence).
Evidence was insufficient to show whether groups differed in clinical pregnancy rates (OR 0.96, 95% CI 0.72 to 1.29, 783 women, I2
= 9%; low-quality evidence).
Trialists provided no usable data for other outcomes of interest.
CSA + PCB versus general anaesthesia
Evidence was insufficient to show whether groups differed in postoperative pain scores (0 to 10 VAS: MD 0.49, 95% CI -0.13 to 1.11,
50 women; very low-quality evidence).
Evidence was insufficient to show whether groups differed in clinical pregnancy rates (OR 0.70, 95% CI 0.22 to 2.26, 51 women; very
low-quality evidence).
Trialists provided no usable data for other outcomes of interest.
CSA + PCB versus spinal anaesthesia
Postoperative pain scores were higher in the CSA + PCB group (0 to 10 VAS: MD 1.02, 95% CI 0.48 to 1.56, 36 women; very low-
quality evidence).
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Evidence was insufficient to show whether groups differed in clinical pregnancy rates (OR 0.93, 95% CI 0.24 to 3.65, 38 women; very
low-quality evidence).
Trialists provided no usable data for other outcomes of interest.
CSA + PCB versus PCB
Evidence was insufficient to show whether groups differed in clinical pregnancy rates (OR 0.93, 95% CI 0.44 to 1.96, 150 women;
low-quality evidence) or satisfaction (OR 1.63, 95% CI 0.68 to 3.89, 150 women, low-quality evidence).
Trialists provided no usable data for other outcomes of interest.
CSA + PCB versus CSA only
Evidence was insufficient to show whether groups differed in clinical pregnancy rates (OR 0.62, 95% CI 0.28 to 1.36, one RCT, 100
women; very low-quality evidence). Rates of postoperative nausea and vomiting were lower in the CS + PCB group (OR 0.42, 95%
CI 0.18 to 0.97, two RCTs, 140 women, I2 = 40%; very low-quality evidence).
Trialists provided no usable data for other outcomes of interest.
Authors’ conclusions
The evidence does not support one particular method or technique over another in providing effective conscious sedation and analgesia
for pain relief during and after oocyte retrieval. Simultaneous use of sedation combined with analgesia such as the opiates, further
enhanced by paracervical block or acupuncture techniques, resulted in better pain relief than occurred with one modality alone.
Evidence was insufficient to show conclusively whether any of the interventions influenced pregnancy rates. All techniques reviewed
were associated with a high degree of patient satisfaction. Women’s preferences and resource availability for choice of pain relief merit
consideration in practice.
P L A I N L A N G U A G E S U M M A R Y
Pain relief for women undergoing oocyte retrieval for assisted reproduction
Review question
Cochrane review authors investigated the effectiveness and safety of methods used for pain relief in women during transvaginal oocyte
retrieval - a technique used to collect eggs from the ovaries, to enable fertilisation outside the body.
Background
Conscious sedation comprises use of a drug or drugs to produce a state of relaxation enabling treatment to be carried out, during which
verbal contact with the patient is maintained throughout the period of sedation. Conscious sedation and analgesia are methods used
to relieve pain during surgery to retrieve eggs from the ovaries as part of in vitro (i.e. in an artificial environment such as a laboratory)
fertilisation procedures. Concerns include that drugs used for sedation and pain relief may have an adverse effect on pregnancy rates.
Study characteristics
This review identified 24 randomised controlled trials, involving 3160 women, comparing the effects of five different methods of
conscious sedation and pain relief including general anaesthesia. A randomised controlled trial uses research methods that aim to reduce
bias when a new treatment is tested by allocating participants at random (i.e. by chance alone) to treatment or control treatment. The
evidence is current to November 2017.
Key results
The evidence does not support one particular method or technique over another in providing effective conscious sedation and analgesia
for pain relief during and after oocyte retrieval. Simultaneous use of sedation combined with analgesia such as the opiates, further
enhanced by techniques of paracervical block or acupuncture, resulted in better pain relief than occurred with one method alone.
Evidence was insufficient to show conclusively whether any of the interventions influenced pregnancy rates. All techniques reviewed
were associated with a high degree of patient satisfaction. It would be appropriate to consider women’s preferences and choice of
resources available for pain relief in practice.
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Quality of the evidence
Evidence is generally of low or very low quality, mainly owing to poor reporting methods and small sample sizes with low event rates.
As women vary in their experience of pain and awareness of coping strategies, the optimal method may be individualised.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Conscious sedation and analgesia (CSA) compared with CSA+acupuncture for women undergoing oocyte retrieval for assisted reproduction
Patient or population: women undergoing oocyte retrieval for assisted reproduct ion
Setting: assisted reproduct ion clinic
Intervention: conscious sedat ion and analgesia (CSA)
Comparison: CSA + acupuncture
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with CSA +
acupuncture
Risk with CSA only
(95% CI)
Intraoperat ive pain Mean intraoperat ive
pain score in the com-
parison group was 4.9
points on a 0 to 10 VAS
Mean score in the CSA-
only group was 1 point
higher
(0.18 higher to 1.82
higher)
- 62
(1 RCT)
⊕©©©
VERY LOWa,b
Postoperat ive pain Mean postoper-
at ive pain score in the
comparison group was
3.2 on a 0 to 10 VAS
Mean score in the CSA-
only group was 0.6
points higher
(0.1 lower to 1.3 higher)
- 61
(1 RCT)
⊕©©©
VERY LOWa,b
Pregnancy 344 per 1000 242 per 1000
(95 to 493)
OR 0.61
(0.20 to 1.86)
61
(1 RCT)
⊕©©©
VERY LOWa,b
Patient sat isfact ion No studies reported this outcome. Not est imable - -
Side ef fects (postoper-
at ive vomit ing and/ or
vomit ing)
156 per 1000 233 per 1000
(78 to 521)
OR 1.64
(0.46 to 5.88)
62
(1 RCT)
⊕©©©
VERY LOWa,b
Postoperat ive compli-
cat ions
No studies reported this outcome. Not est imable - -
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*The risk in the intervention group (and its 95% conf idence interval) is based on the risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; CSA: conscious sedat ion and analgesia; OR: odds rat io; VAS: visual analogue scale
GRADE Working Group grades of evidence.
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded one level for serious risk of bias: unclear risk of bias in one or two domains.
bDowngraded two levels for very serious imprecision: very small sample size and low event rate and/ or wide conf idence
intervals compatible with benef it in either group or no ef fect.
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B A C K G R O U N D
Description of the condition
Transvaginal retrieval of oocytes from the ovary is a fundamental
step of in vitro fertilisation (IVF) treatment. Although this ap-
proach is less invasive and of shorter duration than laparoscopic
retrieval of oocytes, which is no longer common clinical practice,
it remains a stressful and painful procedure, which requires anal-
gesia and conscious sedation (Ng 2001).
Description of the intervention
Conscious sedation is defined by the American Society of Anaes-
thetists as “a drug-induced depression of consciousness during
which patients respond purposefully to verbal commands, either
alone or accompanied by light tactile stimulation. No interven-
tions are required to maintain a patent airway, and spontaneous
ventilation is adequate. Cardiovascular function is usually main-
tained” (ASA 2015). Loss of consciousness should be unlikely due
to the agents and techniques selected (Skelly 1996).
Analgesia is defined as “a state of reduced pain perception” (White
1987). An ideal analgesia is one that has the capability of offering
pain relief without impairing consciousness.
Conscious sedation and analgesia may be combined for optimal
effect. A variety of drugs and combinations thereof have been used
to modify pain and anxiety during oocyte retrieval. Methods cur-
rently used to provide pain relief during transvaginal oocyte re-
trieval include conscious sedation, neuraxial anaesthesia (epidu-
ral or spinal), injection of local anaesthetic agents into the cervix
(paracervical block), and alternative treatments such as acupunc-
ture or electroacupuncture (Sharma 2015). General anaesthesia
may be used for transvaginal oocyte retrieval; however, this ap-
proach has important resource requirements and many IVF units
opt for conscious sedation and analgesia.
The primary goal of clinicians is to provide safe and effective se-
dation and analgesia that contribute to optimum surgical con-
ditions and fast postoperative recovery. The aims of general and
regional (epidural and spinal) anaesthesia are clear. The former
renders the patient unconscious with no awareness of pain, and
the latter achieves the endpoint of no sensation (of pain) while
consciousness is maintained. Sedation, however, is much less clear
or well defined than anaesthesia and has a smaller evidence base
to guide practice. Giving too much or too little sedation can be
hazardous, as toomuch sedation would be dangerous and too little
would be ineffective. In addition, analgesics such as fentanyl and
pethidine in high dosages can produce sedation, and intravenous
anaesthetics such as propofol (sedative and analgesia) at subanaes-
thetic dosages can have sedative effects.
How the intervention might work
The pain experienced by patients during oocyte retrieval is caused
by puncture of vaginal skin and the ovarian capsule by the aspirat-
ing needle and manipulation of the needle within the ovary dur-
ing the procedure. It has been suggested that the pain associated
with oocyte retrieval is intermittent rather than continuous (Zelcer
1992). Thus, an ideal strategy for pain relief is one that allows
maximum flexibility to respond to the changing requirements of
women undergoing oocyte retrieval. Patient-controlled analgesia
may facilitate an individualised approach by allowing women a
degree of control over drug administration.
Acupuncture practices are based on the hypothesis that human
physiological functions are controlled by Yin and Yang channels,
which allow the flow of hypothetical “Qi” through the body (Han
2011). It is believed that blockage of these channels can lead to
illness and pain. Insertion of acupuncture needles into specific
acupuncture sites to resolve blockage and allow free flow of “Qi”
is traditionally believed to relieve patient symptoms and is often
used for pain relief (Han 2011).
Manual acupuncture involves insertion and manipulation of
acupuncture needles within specific predetermined acupuncture
sites. In electrical acupuncture, an additional current is admin-
istered through the acupuncture needles to stimulate acupoints
(Zhao 2008).
Why it is important to do this review
Most oocyte retrievals are performed with the patient under con-
scious sedation: This approach is applied in 84% of IVF clinics
in the UK (Elkington 2003), as well as 95% of IVF centres in the
United States (Ditkoff 1997). However, 16% of UK clinics and
about 50% of clinics in Germany have used general anaesthesia for
IVF procedures (Rjosk 1993). Another survey showed that 48%
of IVF clinics in the UK used conscious sedation; 29% general
anaesthesia; 12% sedation combined with regional anaesthesia;
and 2% regional anaesthesia; 9% offered a choice of anaesthesia
for IVF procedures (Bokhari 1999). These reported variations in
methods used for pain relief raise questions about the potential
advantages and disadvantages of different methods and protocols
for conscious sedation and analgesia. The efficacy of the various
sedative-analgesic combinations, including general anaesthesia, for
women undergoing oocyte retrieval is of interest to practitioners.
This systematic review aims to assess the effectiveness and safety of
different methods of achieving conscious sedation and analgesia
in women undergoing transvaginal oocyte retrieval, in terms of
pain relief during and after the procedure, pregnancy outcomes,
postoperative complications, and patient satisfaction.
O B J E C T I V E S
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To assess the effectiveness and safety of different methods of con-
scious sedation and analgesia for pain relief and pregnancy out-
comes in women undergoing transvaginal oocyte retrieval.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) only and ex-
cluded quasi-randomised and cross-over trials.
Types of participants
Womenundergoing transvaginal oocyte retrieval during IVF treat-
ment.
Types of interventions
1. Conscious sedation and analgesia versus no treatment or
placebo
2. Conscious sedation and analgesia versus different methods
such as general and spinal anaesthesia, including acupuncture
and paracervical block
3. Different protocols of conscious sedation and analgesia
such as patient-controlled or physician-controlled sedation
We excluded from this review trials involving the use of local
anaesthesia such as vaginal lidocaine gel.
Types of outcome measures
Primary outcomes
1. Intraoperative pain score, defined as pain reported during
or immediately after oocyte retrieval as measured on a visual
analogue scale (VAS), a Likert scale, or another defined
numerical or non-numerical scale
2. Postoperative pain score, defined as pain reported at some
time (minutes or hours) after oocyte retrieval as measured on a
VAS, a Likert scale, or another defined numerical or non-
numerical scale
For the purposes of this review, we have defined postoperative pain
as pain measured at some time after oocyte retrieval. In addition,
none of the studies reporting pregnancy defined it, and in this
review, we assumed that clinical pregnancy was reported, unless
otherwise stated.
We converted to a 0 to 10 scale all VAS data related to pain.
Secondary outcomes
1. Live birth rate and ongoing pregnancy rate (beyond 20
weeks) per woman
2. Clinical pregnancy rate per woman (established by
pregnancy test and confirmed by ultrasound)
3. Fertilisation rate per woman
4. Side effects of analgesia (nausea and vomiting)
5. Postoperative complications (airway, blood pressure,
recovery time, spinal headache)
6. Patient satisfaction (women’s reports of satisfaction with
pain relief and anaesthetic care throughout the oocyte retrieval
procedure)
Search methods for identification of studies
Electronic searches
We searched the Cochrane Gynaecology and Fertility Group
(CGFG) Specialised Register (Procite platform), on 11 November
2017, to identify all RCTs that compared different methods of
conscious sedation and analgesia for pain control during oocyte
retrieval (refer to Appendix 1), without language restriction and
in consultation with the CGFG Information Specialist.
We conducted electronic searches within the following electronic
databases.
1. CENTRAL CRSO, web platform (Appendix 2) (searched 9
November 2017).
2. MEDLINE, Ovid platform, (Appendix 3) (searched from
1946 to 9 November 2017).
3. Embase, Ovid platform (Appendix 4) (searched from 1980
to 9 November 2017).
4. PsycINFO, Ovid platform (Appendix 5) (searched from
1806 to 9 November 2017).
5. CINAHL, Ebsco platform (Appendix 6) (searched from
1982 to 9 November 2017).
6. ClinicalTrials.gov search strategy; web platform (Appendix
7) (searched 10 January 2017).
7. WHO ICTRP search strategy, web platform (Appendix 8)
(searched 10 December 2016).
8. Web of Science, web platform (Appendix 9) (searched 12
January 2017).
9. Portal Regional da BVS, web platform (Appendix 10)
(searched 12 January 2017).
10. OpenGrey, web platform (Appendix 11) (searched 12
January 2017).
Searching other resources
We searched and checked the reference lists of the included studies.
We translated one article from Turkish, one from Spanish, and
four from Chinese.
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Data collection and analysis
Selection of studies
Three review authors (IK, EP, RW) independently examined the
titles and abstracts of articles retrieved by the search and retrieved
full texts of all potentially eligible studies. Each review author inde-
pendently applied the selection criteria to the trial reports, resolv-
ing disagreements by discussion and, if necessary, by consultation
with one other review author (SB). IK contacted trial authors for
clarification of details related to study eligibility such as allocation
method.
Data extraction and management
We conducted data collection and analysis in accordance with the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011). Three review authors (IK, EP,RW) independently extracted
data from eligible studies using a data extraction form designed
and pilot-tested by the review authors. Review authors were not
blinded to trial authors or journal of publication when doing this.
We compared results and resolved any differences by discussion.
A fourth review author (SB) resolved any disagreement that arose
between these three review authors. Where information provided
in the published report was insufficient, IK contacted the study
authors to request further information and clarification.
Assessment of risk of bias in included studies
Three review authors (IK, EP, RW) independently assessed each
trial for risk of bias according to the Cochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011).
We assessed random sequence generation, concealment of alloca-
tion, blinding, completeness of outcome data (including use of
intention-to-treat analysis), and selective outcome reporting for
each trial. We also assessed other potential sources of bias. We cat-
egorised each trial as having low, unclear, or high risk of bias for
each domain by applying the standards described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
When the method used to conceal allocation was not reported
clearly, IK contacted the study authors for clarification.
Measures of treatment effect
For dichotomous data, we used the numbers of events in con-
trol and intervention groups of each study to calculate Mantel-
Haenszel odds ratios (ORs). For continuous data, we calculated
the mean difference (MD) between treatment groups. We have
presented 95% confidence intervals (CIs) for all outcomes.
Unit of analysis issues
The primary analysis was per woman randomised. For reported
data that did not allow valid analysis (e.g. ’per cycle’ rather than
’per woman’ when women contributed more than one cycle), we
computed to obtain results ‘per woman’, if possible.
Dealing with missing data
We analysed data on an intention-to-treat basis as far as possible,
and IK contacted the trial authors to request any missing data.
When no additional information was forthcoming, we assumed
any missing data were the result of failure to achieve the outcome.
Assessment of heterogeneity
For each meta-analysis, we assessed statistical heterogeneity by us-
ing I2 and Chi2 statistics. We determined that substantial hetero-
geneity was present if I2 was greater than 50%, or if P < 0.10 in
the Chi2 test for heterogeneity (Higgins 2011). For the remaining
studies, we have presented a descriptive summary of study out-
comes.
Assessment of reporting biases
We planned to present a funnel plot if publication bias was ques-
tionable because some trials had not been identified (Higgins
2011), but no analysis included sufficient studies to warrant this.
Data synthesis
When appropriate, we combined dichotomous data formeta-anal-
ysis using RevMan software and the Mantel-Haenszel method to
estimate pooled ORs with 95% CIs based on a fixed-effect model.
For continuous data, we computed weighted MDs with 95% CIs,
also using a fixed-effect model in the meta-analysis.
We classified and analysed interventions under broad categories or
strategies of pain relief, for example, types of conscious sedation
and analgesia methods and administration protocols. The inter-
ventions examined were so diverse that it was not possible to quan-
titatively combine the results of all 24 studies. However, we were
able to combine the data from four trials that compared the effects
of electro-acupuncture versus conventional medical analgesia. We
also attempted meta-analysis of the four trials comparing patient-
controlled and physician-controlled sedation and analgesia. For
the remaining studies, we have presented a descriptive summary
of the outcomes of each trial.
Subgroup analysis and investigation of heterogeneity
We did not perform subgroup analysis in this review. We assessed
statistical heterogeneity using the Chi2 test (with P < 0.1 as ev-
idence of significant heterogeneity) and the I2 statistic (Higgins
2011).
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Sensitivity analysis
We performed sensitivity analysis for the primary outcomes to
assess whether findings of the analysis were robust, or whether
the conclusions would have differed if eligibility was restricted to
studies without high risk of bias.
Overall quality of the body of evidence: “Summary of
findings” table
We prepared “Summary of findings” tables using GRADEpro and
Cochranemethods (Higgins 2011). These tables evaluate the over-
all quality of the body of evidence for review outcomes (intraop-
erative pain, postoperative pain, pregnancy outcomes, side effects
of analgesia (nausea and vomiting), postoperative complications,
and patient satisfaction) for the main review comparisons (con-
scious sedation and analgesia vs other active interventions; con-
scious sedation and analgesia plus paracervical block vs other active
interventions). We assessed the quality of evidence using the fol-
lowing GRADEpro criteria: risk of bias, consistency of effect, im-
precision, indirectness, and publication bias. Two review authors
working independently made judgements about evidence quality
(high, moderate, low, or very low) and resolved disagreements by
discussion. Review authors justified, documented, and incorpo-
rated judgements into reporting of results for each outcome.
R E S U L T S
Description of studies
See Characteristics of included studies.
Results of the search
In the original review, our search strategy yielded 390 reports, 27
of which were potentially eligible for inclusion in the review. After
full-text review, we excluded 16 reports because conscious sedation
was not one of the comparators (see Characteristics of excluded
studies). Twelve papers met our inclusion criteria (Ben-Shlomo
1999; Bhattacharya 1997; Cook 1993; Humaidan 2004; Lok
2002; Ng 2001; Ocal 2002; Ramsewak 1990; Stener-Victorin
1999; Stener-Victorin 2003; Thompson 2000; Zelcer 1992).
These trials involved 1350 women who underwent oocyte re-
trieval. For the 2012 review update, we identified nine additional
studies involving 1624 women (Coskun 2011; Gejervall 2005;
Guasch 2005; Gunaydin 2007; Ma 2008; Meng 2008; Meng
2009; Ozturk 2006; Sator-Katzenschlager 2006). For the 2018 re-
view update, we identified three new studies involving 186 women
(Elnabtity 2017; Lier 2014; Matsota 2012).
The study flow is shown in Figure 1.
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Figure 1. Study flow diagram.
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Included studies
We included in this review a total of 24 studies involving 3160
women (see Characteristics of included studies).
Study design and setting
All 24 included studies were RCTs published between 1990 and
2017. They involved a total of 3160 women (range 30 to 700) and
were conducted in Austria (N = 1), China (N = 5), Israel (N = 1),
Spain (N = 1), Sweden (N = 4), the Netherlands (N = 1), Greece
(N = 1), Turkey (N = 4), Eygpt (N = 1), UK (N = 4), and USA (N=
1). Two were multi-centred trials, one involving three IVF centres
(Stener-Victorin 1999), and the other involving five IVF centres
(Stener-Victorin 2003). None of these trials reported specifically
that participants included egg donors. We did not identify any
quasi-randomised or cross-over trials.
Participants
The studies included 3160 women - 1545 in control groups and
1615 in intervention groups. Two trials did not report participant
age (Cook 1993; Ramsewak 1990). Overall age reported in the
other studies was similar, andmean participant age was between 31
and 34 years (range 22 to 46 years). All participants were women
with infertility problems due to tubal factors, endometriosis, poly-
cystic ovary syndrome (PCOS),male factors, or unexplained infer-
tility. Three trials reported the duration of infertility as about four
to five years (Bhattacharya 1997; Elnabtity 2017; Meng 2009).
Interventions
Interventions varied substantially between studies, and review au-
thors grouped them into five broad categories for comparison.
1. Conscious sedation and analgesia versus placebo
(Ramsewak 1990).
2. Conscious sedation and analgesia versus other active
interventions such as general and acupuncture anaesthesia
(Ben-Shlomo 1999; Matsota 2012; Meng 2008; Meng 2009;
Sator-Katzenschlager 2006).
3. Conscious sedation and analgesia plus paracervical block
versus other active interventions such as general, spinal, and
acupuncture anaesthesia (Gejervall 2005; Guasch 2005;
Gunaydin 2007; Humaidan 2004; Ng 2001; Ozturk 2006;
Stener-Victorin 1999; Stener-Victorin 2003).
4. Patient-controlled conscious sedation and analgesia versus
physician-administered conscious sedation and analgesia
(Bhattacharya 1997; Lier 2014; Lok 2002; Thompson 2000;
Zelcer 1992).
5. Conscious sedation and analgesia with different agents or
dosages (Cook 1993; Coskun 2011; Ma 2008; Ocal 2002).
Outcomes
Primary outcomes
1. A total of 22 studies reported intraoperative pain
2. In all, 11 studies reported postoperative pain (Ben-Shlomo
1999; Elnabtity 2017; Gejervall 2005; Guasch 2005; Humaidan
2004; Lier 2014; Lok 2002; Meng 2008; Sator-Katzenschlager
2006; Stener-Victorin 1999; Stener-Victorin 2003)
3. Two studies reported the primary outcomes of pain but did
not specify whether pain was measured intraoperatively or
postoperatively (Meng 2009; Thompson 2000)
4. Two studies did not report the primary outcomes of pain
(Cook 1993; Matsota 2012)
Secondary outcomes
1. 1/24 studies reported live birth per woman (Stener-Victorin
1999)
2. 2/24 studies reported ongoing pregnancy per woman (Lier
2014; Stener-Victorin 2003)
3. 14/24 studies reported clinical pregnancy rate per woman
(Ben-Shlomo 1999; Coskun 2011; Gejervall 2005; Guasch
2005; Humaidan 2004; Lier 2014; Lok 2002; Matsota 2012; Ng
2001; Ozturk 2006; Sator-Katzenschlager 2006; Stener-Victorin
1999; Stener-Victorin 2003; Thompson 2000)
4. 5/24 studies reported fertilisation rate per woman
(Ben-Shlomo 1999; Lok 2002; Matsota 2012; Ng 2001; Ozturk
2006)
5. 13/24 studies reported side effects (nausea and vomiting)
(Coskun 2011; Elnabtity 2017; Guasch 2005; Gunaydin 2007;
Lier 2014; Ma 2008; Matsota 2012; Meng 2009; Ozturk 2006;
Sator-Katzenschlager 2006; Stener-Victorin 1999;
Stener-Victorin 2003; Zelcer 1992)
6. 5/24 studies reported complications (transient loss of
consciousness; loss of airway) (Cook 1993; Coskun 2011;
Guasch 2005; Matsota 2012; Thompson 2000)
7. 15/24 studies reported patient satisfaction (Ben-Shlomo
1999; Bhattacharya 1997; Cook 1993; Coskun 2011; Elnabtity
2017; Gejervall 2005; Guasch 2005; Gunaydin 2007; Lier 2014;
Lok 2002; Matsota 2012; Ng 2001; Ozturk 2006;
Sator-Katzenschlager 2006; Thompson 2000)
No studies reported the incidence of abandoned procedures.
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Excluded studies
See Characteristics of excluded studies.
After full-text screening, we excluded 25 studies for the following
reasons.
1. 20/25 studies did not include conscious sedation and
analgesia as a comparator.
2. 1/25 studies did not provide clear inclusion criteria for the
population and we received no response from trial authors when
contacted.
3. 1/25 studies compared conscious sedation and analgesia
between different populations.
4. 3/25 studies were abstracts, and we were unable to obtain
evidence of randomisation.
Risk of bias in included studies
See Risk of bias in included studies, Figure 2, and Figure 3.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Nineteen studies were at low risk of selection bias related to ran-
dom sequence generation, as they used computer randomisation
or a random numbers table. Six studies were at unclear risk of bias,
as they did not describe the randomisation method used (Cook
1993; Elnabtity 2017; Gunaydin 2007; Ocal 2002; Ozturk 2006;
Zelcer 1992). Eight studies did not describe allocation conceal-
ment and were at unclear risk of bias in this domain (Gejervall
2005;Guasch 2005; Lier 2014;Ma 2008;Meng 2009; Ocal 2002;
Sator-Katzenschlager 2006; Zelcer 1992).
Blinding
Blinding status could affect findings for the outcomes of pain, side
effects, and women’s satisfaction. The subjective nature of pain has
traditionally made it difficult to assess the efficacy of techniques
for analgesia. We did not consider that blinding was likely to in-
fluence risk of performance bias for the outcomes of live birth and
ongoing pregnancy. However, we noted the potential for bias for
the outcomes of fertilisation and subsequent clinical pregnancy
when operators were not blinded to allocation. Three studies re-
ported adequate blinding of administrators of interventions to
group allocation (Gejervall 2005; Ng 2001; Sator-Katzenschlager
2006), and we consider these studies to be at low risk of bias.
For 17 studies, blinding was not possible because of the nature of
interventions such as general anaesthesia or techniques involving
paracervical block (Ben-Shlomo 1999; Bhattacharya 1997; Cook
1993; Gejervall 2005; Gunaydin 2007; Humaidan 2004; Lier
2014; Lok 2002; Matsota 2012; Meng 2008; Meng 2009; Ocal
2002; Ozturk 2006; Stener-Victorin 1999; Stener-Victorin 2003;
Thompson 2000; Zelcer 1992), and we consider these studies to
be at unclear risk of bias. Three studies described use of placebo
identical to the intervention and were deemed to be at low risk of
performance bias for both subjective and objective outcomes (Ng
2001; Ramsewak 1990; Sator-Katzenschlager 2006).
Seven studies described blinding of outcome assessors for sub-
jective outcomes of pain (Cook 1993; Gejervall 2005; Guasch
2005;Matsota 2012;Ng 2001; Sator-Katzenschlager 2006; Zelcer
1992), and we consider these studies to be at low risk of perfor-
mance bias for subjective outcomes. In one study (Coskun 2011),
an independent blinded observer unaware of the women’s alloca-
tion status recorded postoperative side effects.
Incomplete outcome data
Eighteen studies analysed all ormost (> 99%) randomisedwomen,
and we judged these studies to be at low risk of bias. For three
studies, loss to follow-up ranged from 4% to 20% (Lok 2002;
Ramsewak 1990; Stener-Victorin 2003). We judged these studies
to be at unclear to high risk of attrition bias.
Selective reporting
All 24 studies reported outcomes prespecified in the methods sec-
tion. Some outcomes such as plasma prolactin and follicular cor-
tisol levels, sedation concentrations, recovery status, number of
embryos transferred, oocyte retrieval rate, psychometric tests, and
neuropeptide Y (NPY) level of follicular fluid were not of interest
for this review (Cook 1993; Coskun 2011;Gejervall 2005;Guasch
2005; Gunaydin 2007; Ng 2001; Ozturk 2006); we neither ex-
tracted nor analysed these data.
Other potential sources of bias
We assessed publication bias by using a funnel plot for primary
outcomes when appropriate. Ten studies did not compare causes
of infertility in intervention and control groups (Ben-Shlomo
1999; Cook 1993; Coskun 2011; Guasch 2005; Gunaydin 2007;
Meng 2009; Ocal 2002; Ramsewak 1990; Thompson 2000;
Zelcer 1992). Demographic details were absent from one study
(Ramsewak 1990), and another study reported only women’s age
(Ocal 2002). The risk of bias related to potential baseline differ-
ences between the two groups in these studies cannot be estab-
lished, and we consider these studies to be at unclear risk of bias.
In one study, women in the control group were younger than those
in the intervention groups, although the cause of infertility was
similar between groups (Lok 2002). We found no additional po-
tential sources of other bias in the remaining studies.
Effects of interventions
See: Summary of findings for the main comparison Conscious
sedation and analgesia (CSA) compared with CSA+acupuncture
for women undergoing oocyte retrieval for assisted reproduction;
Summary of findings 2 Conscious sedation and analgesia (CSA)
comparedwithCSA+ electro-acupuncture forwomen undergoing
oocyte retrieval for assisted reproduction; Summary of findings 3
Conscious sedation and analgesia compared with general analgesia
for women undergoing oocyte retrieval for assisted reproduction;
Summary of findings 4 Conscious sedation and analgesia (CSA)
+ paracervical block (PCB) versus electro-acupuncture + PCB;
Summary of findings 5Conscious sedation and analgesia (CSA) +
paracervical block (PCB) versus general anaesthesia; Summary of
findings 6Conscious sedation and analgesia (CSA) + paracervical
block (PCB) versus spinal anaesthesia; Summary of findings
7 Conscious sedation and analgesia (CSA) + paracervical block
(PCB) versus PCB; Summary of findings 8 Conscious sedation
and analgesia (CSA) + paracervical block (PCB) versus CSA
We have summarised the effects of interventions as follows.
1. Conscious sedation and analgesia versus placebo.
2. Conscious sedation and analgesia versus other active
interventions.
15Pain relief for women undergoing oocyte retrieval for assisted reproduction (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
3. Conscious sedation plus paracervical block versus other
active interventions.
4. Conscious sedation and analgesia: patient-controlled versus
physician-controlled.
5. Conscious sedation and analgesia via different agents or
dosages.
1. Conscious sedation and analgesia versus placebo
Only one study made this comparison (Ramsewak 1990).
Primary outcome
1.1 Intraoperative pain
Conscious sedation and analgesia was associated with less pain
than placebo during needle insertion (mean difference (MD) on
0 to 10 VAS -1.70, 94% CI -2.38 to -1.02; N = 24; Analysis 1.1)
and with less pain during follicle aspiration (MD on 0 to 10 VAS
-1.30, 95% CI -1.88 to -0.72; N = 24; Analysis 1.2).
Other outcomes were not reported.
2. Conscious sedation and analgesia (CSA) versus
other active interventions
Five studies made the following comparisons.
1. CSA plus placebo acupuncture versus CSA plus electro-
acupuncture or acupuncture (Sator-Katzenschlager 2006).
2. CSA versus CSA plus electro-acupuncture (Meng 2008;
Meng 2009).
3. CSA versus general anaesthesia (Ben-Shlomo 1999;
Matsota 2012).
Primary outcomes
2.1 Intraoperative pain
See Analysis 2.1.
CSA plus placebo acupuncture versus CSA plus acupuncture
or electro-acupuncture
CSA plus placebo acupuncture (i.e. CSA without acupuncture)
was associatedwith a higher pain score during oocyte retrieval than
CSA plus acupuncture (MD on 0 to 10 VAS 1.00, 95% CI 0.18
to 1.82; N = 62; very low-quality evidence) or CSA plus electro-
acupuncture (MD on 0 to 10 VAS 3.00, 95% CI 2.23 to 3.77; N
= 62; very low-quality evidence) (Sator-Katzenschlager 2006).
This finding was supported by another study in which CSA only
was associated with more pain during oocyte retrieval than con-
scious sedation plus electro-acupuncture (MD on 1 to 12 numer-
ical rating scale 1.7, 95% CI 1.07 to 2.33; N = 316). In this study,
99/170 (58%) versus 120/146 (82%) women rated pain as mild;
69/170 (41%) versus 23/146 (16%) rated pain as moderate; and
2/170 (1.2%) versus 3/146 (2%) rated pain as severe (P < 0.01)
during oocyte retrieval (Meng 2008).
2.2 Postoperative pain
See Analysis 2.2.
CSA plus acupuncture versus CSA plus acupuncture or
electro-acupuncture
Postoperative pain was greater in the CSA plus placebo acupunc-
ture (i.e. CSA without acupuncture) group than in the CSA plus
acupuncture group (MDon0-10VAS0.60, 95%CI -0.10 to 1.30;
N = 61; very low-quality evidence) (Figure 4 Sator-Katzenschlager
2006).
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Figure 4. Forest plot of comparison: 2 Conscious sedation + analgesia (CSA) versus other active
interventions, outcome: 2.2 Postoperative pain.
CSA plus placebo acupuncture was associated with a higher pain
score after oocyte retrieval than conscious sedation plus electro-
acupuncture (MD on 0-10 VAS 2.10, 95% CI 1.40 to 2.80; N =
61; very low-quality evidence) (Sator-Katzenschlager 2006).
This finding was supported by two other studies, which reported
binary data, and in which conscious sedation only was associated
with more pain at one hour postoperatively when compared with
conscious sedation plus electro-acupuncture (100/170 (59%) vs
47/146 (32%) reported pain), as well as at two to five hours post-
operatively (70/170 (42%) vs 38/146 (26%) reported pain; P <
0.01; N = 316) (Meng 2008). Similarly, conscious sedation plus
electro-acupuncture was reported to be associated with lower cu-
mulative pain scores than conscious sedation alone (insufficient
data details; N = 694) (Meng 2009).
CSA versus general anaesthesia
CSA was associated with less pain (Likert scale 0 to 3) 30 minutes
after completion of the procedure when compared with general
anaesthesia (MD on 0 to 3 Likert scale -1.90, 95% CI -2.24 to -
1.56; N = 50; very low-quality evidence) (Ben-Shlomo 1999).
Secondary outcomes
2.3 Live birth rate and ongoing pregnancy rate
These outcomes were not reported.
2.4 Clinical pregnancy rate
See Analysis 2.3.
Data show no clear evidence of a difference in pregnancy rate
between CSA plus placebo and CSA plus acupuncture (OR 0.61,
95%CI 0.20 to 1.86; N = 61; P = 0.38; very low-quality evidence)
(Sator-Katzenschlager 2006).
CSA plus placebo acupuncture was associated with a lower preg-
nancy rate per woman when compared with CSA plus electro-
acupuncture (OR 0.22, 95% CI 0.07 to 0.66; N = 61; very low-
quality evidence) (Sator-Katzenschlager 2006).
Two studies reported that when researchers compared CSA with
general anaesthetic, they found no evidence of a difference in the
clinical pregnancy rate per woman (OR 1.00, 95% CI 0.43 to
2.35; two RCTs; N = 108; I2 = 0%; very low-quality evidence;
Analysis 2.3) (Ben-Shlomo 1999; Matsota 2012).
2.5 Fertilisation rate
No study reported this outcome. One study reported oocyte fer-
tilisation rate per oocytes retrieved (Matsota 2012).
2.6 Abandoned procedure of oocyte retrieval
This outcome was not reported.
2.7 Side effects of analgesia
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See Analysis 2.4.
When investigators compared CSA plus placebo acupuncture ver-
sus CSA plus acupuncture, they provided insufficient evidence to
show whether there was a difference in the number of women re-
porting nausea during oocyte retrieval (OR 1.64, 95% CI 0.46 to
5.88; N = 62; very low-quality evidence). Similarly, when compar-
ing CSA plus placebo acupuncture versus conscious sedation plus
electro-acupuncture, investigators found no clear evidence of dif-
ferences between groups for this outcome (OR 1.09, 95% CI 0.33
to 3.58; N = 62; very low-quality evidence). Two of 29 women
(7%) in the CSA plus placebo group reported nausea and vomit-
ing versus none in the other two groups one hour post treatment
(Sator-Katzenschlager 2006).
When investigators compared CSA plus placebo acupuncture ver-
sus conscious sedation plus electro-acupuncture, they found no
clear evidence of a difference in reported side effects for nausea
and vomiting during oocyte retrieval (17/146 (12%) vs 28/170
(16%) and 3/146 (2%) vs 3/170 (1.8%), respectively; N = 80)
nor at one hour postoperatively (13/146 (9%) vs 19/170 (11%)
and 4/146 (2.7%) vs 2/170 (1.2%), respectively) nor at two to
five hours postoperatively (15/146 (10%) vs 26/170 (15%) and
11/146 (7.5%) vs 15/170 (9%), respectively) (Meng 2008).
When comparing CSAwith general anaesthetic, researchers found
insufficient evidence to show whether there was a difference in
postoperative vomiting (OR 0.46, 95% CI 0.08 to 2.75; N = 50)
(Ben-Shlomo 1999). In another study, researchers found no evi-
dence of a difference in the number of women experiencing fewer
than two episodes of vomiting (0/29 (0%) versus 2/29 (6.9%),
and women experiencing more than two episodes of vomiting (0/
29 (0%) versus 0/29 (0%), P = 0.15; respectively) (Matsota 2012).
2.8 Postoperative complications
See Analysis 2.6 and Analysis 2.7.
When comparing CSA versus general anaesthetic, investigators
found no clear evidence of a difference in the rate of airway ob-
struction (OR 0.14, 95% CI 0.02 to 1.22; N = 58; very low-qual-
ity evidence), but fewer women in the conscious sedation group
needed mask ventilation (OR 0.05, 95% CI 0.01 to 0.20; N = 58;
very low-quality evidence) (Matsota 2012).
2.9 Patient satisfaction
When comparing CSA versus general anaesthesia, researchers
found that women in both CSA and general anaesthesia groups
were satisfied with the modality of pain relief and provided no
evidence of a difference between groups, at 24/25 (96%) versus
25/25 (100%) (Ben-Shlomo 1999). In another study, in which
researchers did not assess pain as an outcome, women in both CSA
and general anaesthesia groups were satisfied with treatment and
were willing to repeat the procedure using the same anaesthesia
protocols (27/29 (93%) vs 29/29 (100%)) (Matsota 2012). Com-
bined data from these two studies show an OR of 0.66 (95% CI
0.11 to 4.04; two RCTs; N = 108; I2 = 34%; very low-quality
evidence; Analysis 2.5) (Ben-Shlomo 1999; Matsota 2012).
3. Conscious sedation plus paracervical block (PCB)
versus other active interventions
Eight studies compared these interventions as follows.
1. CSA plus PCB versus general anaesthesia (Guasch 2005).
2. CSA plus PCB versus spinal anaesthesia (Guasch 2005).
3. CSA plus PCB versus placebo plus PCB (Ng 2001).
4. CSA plus PCB versus CSA alone (Gunaydin 2007; Ozturk
2006).
5. CSA plus PCB versus electro-acupuncture plus PCB
(Gejervall 2005; Humaidan 2004; Stener-Victorin 1999;
Stener-Victorin 2003).
Primary outcomes
3.1 Intraoperative pain
See Analysis 3.1 and Figure 5.
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Figure 5. Forest plot of comparison: 3 Conscious sedation + paracervical block versus other interventions,
outcome: 3.1 Intraoperative pain (VAS).
Four trials reported data suitable for analysis (Gejervall 2005;
Humaidan 2004; Stener-Victorin 1999; Stener-Victorin 2003),
showing that CSA plus PCB was associated with less intraoper-
ative pain during oocyte retrieval when compared with electro-
acupuncture plus PCBMD on a VAS 0 to 10 scale of -0.66 (95%
CI -0.93 to -0.39; four RCTs; N = 781; I2 = 76%; low-quality
evidence). Heterogeneity was high, but the direction of effect was
consistent.
Three trials reported data unsuitable for analysis (Gunaydin 2007;
Ng 2001; Ozturk 2006).
Investigators in Ng 2001 found that CSA plus PCB was associated
with less pain when compared with placebo plus PCB (median on
0 to 10 VAS scale 1.2 vs 3.0 during vaginal punctures, and 1.65
vs 4.30 for corresponding abdominal pain, respectively).
When comparing CSA plus PCB versus CSA only, researchers
measured pain at five-minute intervals during oocyte retrieval and
found that CSA plus PCB was associated with less pain (mean
VAS) when compared with CSA only (data presented graphically;
N = 40) (Gunaydin 2007). Trialists considered a pain score higher
than 3 on a simple numerical rating scale (SNRS) as significant.
In a second study of the same comparison, CSA plus PCB was
associated with less pain than CSA only at the first ovarian punc-
ture (SNRS > 3: 0/50 (0%) vs 6/50 (12%); P < 0.05; N = 100)
but SNRS scores at the second ovarian puncture were similar in
the two groups (SNRS > 3: 3/50 (6%) vs 3/50 (6%); N = 100)
(Ozturk 2006).
3.2 Postoperative pain
See Analysis 3.2.
CSA plus PCB was associated with a higher pain score at four
hours postoperatively than was obtained with general anaesthesia
(MD on 0 to 10 VAS scale of 0.49, 95% CI -0.13 to 1.11; N =
50; very low-quality evidence). CSA plus PCB was associated with
a higher pain score when compared with spinal anaesthesia (MD
on 0 to 10 VAS scale 1.02, 95% CI 0.48 to 1.56; N = 36; very
low-quality evidence) (Guasch 2005).
Trials yielding data unsuitable for analysis have reported that when
CSA plus PCBwas compared with electro-acupuncture plus PCB,
data show no difference in pain between the two groups at 30
minutes (Humaidan 2004) nor at 60 minutes (Gejervall 2005)
after oocyte retrieval. At two hours after retrieval, one trial found
less pain in the electro-acupuncture plus PCB group than in the
CSA plus PCBgroup (medianVAS 1.1, 95%CI 0 to 7 vs 1.6, 95%
CI 0 to 9; P < 0.01; N = 274) (Stener-Victorin 2003), but the other
trial reported no meaningful differences between groups (mean
VAS 2.29 (SD 2.34) vs 2.18 (SD 2.14); N = 149) (Stener-Victorin
1999).
Secondary outcomes
3.3 Live birth rate and ongoing pregnancy rate
See Analysis 3.3.
CSA plus PCB was associated with a higher live birth rate per
woman than was electro-acupuncture plus PCB (OR 2.35, 95%
CI 1.09 to 5.05; N = 149) (Stener-Victorin 1999). Researchers
provided no clear evidence of a difference between the two groups
in ongoing pregnancy rates per woman (OR 0.86, 95% CI 0.50
to 1.47; N = 274) (Stener-Victorin 2003).
3.4 Clinical pregnancy rate
See Analysis 3.4.
Evidence is insufficient to show whether there was a difference in
pregnancy rates when researchers compared CSA versus general
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anaesthesia (OR 0.70, 95% CI 0.22 to 2.26; N = 51; very low-
quality evidence) or versus spinal anaesthesia (OR 0.93, 95% CI
0.24 to 3.65; N = 38; very low-quality evidence) (Guasch 2005).
When CSA with PCB was compared with placebo plus PCB,
evidence was insufficient to show whether there was a difference
between the two groups in clinical pregnancy rate (OR 0.93, 95%
CI 0.44 to 1.96; N = 150; Analysis 3.4) (Ng 2001).
Data show no evidence of a difference in pregnancy rates between
electro-acupuncture plus PCB and CSA plus PCB (OR0.96, 95%
CI 0.72 to 1.29; four RCTs; N = 783; I2 = 9%) and no significant
heterogeneity (P = 0.78; Analysis 3.4) (Gejervall 2005; Humaidan
2004; Stener-Victorin 1999; Stener-Victorin 2003).
CSA plus PCB was associated with a lower pregnancy rate per
woman when compared with CSA alone (OR 0.62, 95% CI 0.28
to 1.36; N = 100) (Ozturk 2006).
3.5 Fertilisation rate
Comparison of CSA with PCB versus placebo plus PCB yielded
no evidence of a difference between the two groups in fertilisation
rates (OR 0.83, 95% CI 0.42 to 1.66; N = 150; Analysis 3.5) (Ng
2001).
Comparison of CSA alone versus CSA with PCB yielded no ev-
idence of a difference between groups in fertilisation rate per
woman (35/50 (69.8%) vs 37/50 (73.3%); N = 100) (Ozturk
2006).
3.6 Abandoned procedure of oocyte retrieval
This outcome was not reported.
3.7 Side effects of analgesia
Two trials compared CSA and PCB versus CSA alone (Gunaydin
2007; Ozturk 2006). CSA with PCB was associated with a lower
likelihood of nausea and vomiting when compared with CSA only
(OR 0.42, 95% CI 0.18 to 0.97; two RCTs; N = 140; I2 = 40%;
very low-quality evidence). Data show no statistically significant
heterogeneity (P = 0.26; Analysis 3.6).
Two trials reported data unsuitable for analysis (Guasch 2005; Ng
2001).
Trials comparing CSA plus PCB versus electro-acupuncture plus
PCB have provided no evidence of a difference in reports of nausea
between the two groups at recovery (mean VAS 6.5 (13.0) vs 4.6
(8.8); N = 158) (Gejervall 2005) or at two hours after oocyte
retrieval (mean VAS 4.1 (SD 8.0) vs 3.0 (SD 7.2); N = 149)
(Stener-Victorin 1999). Another study reported less nausea in the
electro-acupuncture and PCB group (2/136 (1.5%) vs 13/138
(9.4%) (VAS < 75; P < 0.01; N = 274) (Stener-Victorin 2003).
3.8 Postoperative complications
This outcome was not reported.
3.9 Patient satisfaction
Comparisons of CSA plus PCB versus general or spinal anaesthesia
show that all women reported a high degree of satisfaction (90%
vs 88% vs 90%, respectively) (Guasch 2005).
Comparisons of CSA with PCB versus placebo plus PCB yielded
no evidence of a difference in satisfaction rates, at 88% versus 80%
who were very satisfied or satisfied (OR 1.63, 95% CI 0.68 to
3.89; N = 150; Analysis 3.7) (Ng 2001).
Comparisons of CSA with PCB versus CSA alone yielded no ev-
idence of a difference in satisfaction rates between groups in ei-
ther trial (47/50 (94%) vs 48/50 (96%) and 20/20 (100%) vs 20/
20 (100%) rated satisfaction as moderate and good, respectively)
(Gunaydin 2007; Ozturk 2006).
Data show that when CSA plus PCB was compared with electro-
acupuncture plus PCB, electro-acupuncture plus PCB was associ-
ated with a higher satisfaction score in relation to oocyte aspiration
than CSA plus PCB (VAS 15.3 (SD 16.3) vs 9.8 (SD 12.6); P =
0.039; N = 158) (Gejervall 2005).
4. Patient-controlled conscious sedation and analgesia
(CSA) versus physician-controlled CSA
Five studies compared these interventions (Bhattacharya 1997;
Lier 2014; Lok 2002;Thompson 2000;Zelcer1992).One of these
studies reported that patient-controlled CSA was administered
with the use of inhalational isodesox (Thompson 2000).
Primary outcomes
4.1 Intraoperative pain
Two trials found that patient-controlled CSA was associated with
higher pain scores than were reported with physician-controlled
CSA (meanVAS 0 to 10 scale 5.3 vs 3.5;N =106; and 4.68 vs 3.41;
N = 112, respectively) (Lok 2002; Thompson 2000). Trialists in
the other two studies found no evidence of a difference between
groups (mean VAS 0 to 10 scale 3.85 vs 4.63; N = 81; and 2.9
vs 2.5; N = 80, respectively) (Bhattacharya 1997; Zelcer 1992).
Combined data on intraoperative pain scores from these four trials
show amean difference in VAS of 0.60 (95%CI 0.16 to 1.03; four
RCTs; N = 379; I2 = 83%; Analysis 4.1) (Figure 6) and significant
heterogeneity (P = 0.006) favouring physician-controlled CSA.
Exclusion of the single trial in which patient-controlled CSA was
administered with the use of inhalational isodesox yielded a mean
VAS score of 0.47 (95% CI -0.01 to 0.95; three RCTs; N = 271; I
2 = 87%; Analysis 4.2) and significant statistical heterogeneity (P
= 0.004) (Thompson 2000).
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Figure 6. Forest plot of comparison: 4 Patient-controlled versus physician-controlled sedation + analgesia
(CSA), outcome: 4.1 Intraoperative pain score (VAS 0 to 10).
In a study without data suitable for analysis, the numeric rating
scale (NRS) pain score in the patient-controlled CSA group was
lower than in the physician-administered CSA group but the dif-
ference did not reach statistical significance (median NRS 4 (3 to
7) vs 6 (4 to 8); P = 0.13; one RCT; N = 76) (Lier 2014).
4.2 Postoperative pain
Patient-controlledCSAwas associatedwith higher pain scores than
physician-controlled CSA two hours after oocyte retrieval (MD
on a 0 to 10 VAS scale 1.20, 95% CI 0.26 to 2.14; N = 106;
Analysis 4.3) (Lok 2002).
In the study without data suitable for analysis, the pain score in
the patient-controlledCSA group 30minutes after oocyte retrieval
was higher than in the physician-controlled CSA group (median
NRS 2 (1 to 5) vs 1 (0 to 3); P = 0.016;N =76), but this occurred at
the cost of higher sedation in the physician-controlled CSA group.
Pain and discomfort five days post puncture were similar between
the two groups (pain scores in NRS presented graphically) (Lier
2014).
Secondary outcomes
4.3 Ongoing pregnancy rate and clinical pregnancy rate
Data show no clear evidence of a difference in pregnancy rates per
woman between patient-controlled and physician-administered
CSA (OR 0.90, 95% CI 0.51 to 1.60; three RCTs; N = 294; I2
= 0%; P = 0.48; Analysis 4.4) (Lier 2014; Lok 2002; Thompson
2000).
4.4 Fertilisation rate
Comparisons of patient-controlled CSA versus physician-admin-
istered CSA yielded no evidence of a difference between the two
groups in fertilisation rate per woman (OR 1.17, 95% CI 0.54 to
2.50; N = 106; Analysis 4.5) (Lok 2002).
4.5 Abandoned procedure of oocyte retrieval
One study reported that oocyte retrieval was completed in all trial
participants (Lier 2014).
4.6 Side effects of analgesia
Comparisons of patient-controlled CSA versus physician-admin-
istered CSA yielded no evidence of a difference between the two
groups in the degree of nausea noted during retrieval (nausea score
5.0 (SD 9.0) vs 9.0 (SD 18.0)) or two hours after oocyte retrieval
(nausea score 7.0 (SD 1.0) vs 13.0 (18.0)) (Lok 2002) nor in the
occurrence of postoperative nausea (8% vs 8%) (OR 1.00, 95%
CI 0.19 to 5.28; N = 80; Analysis 4.6) and vomiting (3% vs 0%)
(Zelcer 1992).
Data show no evidence of a difference between the patient-con-
trolled CSA group and the physician-controlled CSA group in re-
ports of ’drowsiness or spinning sensations’ and ’dry mouth’ during
the oocyte retrieval procedure (20/36 (56%) vs 15/40 (38%), and
4/36 (11%) vs 14/40 (35%)). At 30 minutes after completion of
the procedure, ’drowsiness or spinning sensations’ were reported
less frequently in the patient-controlled CSA group than in the
physician-controlledCSA group (4/36 (11.1%) vs 21/40 (52.5%);
P < 0.001) (Lier 2014).
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4.6 Postoperative complications
Trialists have reported that when patient-controlledCSAwas com-
pared with physician-administered CSA in 112 women, one indi-
vidual in the group in which patient-controlled CSA was admin-
istered via inhalational isodesox needed airway support perioper-
atively (Thompson 2000).
4.7 Patient satisfaction
Data show no evidence of a difference between the two groups
in reported satisfaction with the procedure (OR 1.95, 95% CI
0.34 to 11.28; N = 81; Analysis 4.7) (Bhattacharya 1997), nor in
patient satisfaction (MD on VAS 0 to 10 scale 0.20, 95% CI -
0.64 to 1.04; N = 106; Analysis 4.8) (Lok 2002); satisfaction was
high in both groups (95% vs 95%) (Thompson 2000).
The patient-controlled CSA group reported a higher satisfaction
score than was reported by the physician-controlled CSA group
(median NRS 9 (8 to 10) vs 7 (4 to 9); P = 0.013) (Lier 2014).
5. Conscious sedation and analgesia (CSA) via
different agents or dosages
Five studies compared different drug regimens for CSA.
1. CSA with pethidine versus pethidine plus piroxicam (Ocal
2002).
2. CSA with midazolam plus fentanyl versus CSA with
propofol plus fentanyl (Ma 2008).
3. CSA with dexmedetomidine + paracervical block versus
CSA with midazolam + paracervical block (Elnabtity 2017).
4. Patient-controlled CSA with propofol versus patient-
controlled CSA with midazolam (Cook 1993).
5. Target-controlled infusion of CSA plus propofol and
remifentanil, with comparison of different infusion rates
(Coskun 2011).
Primary outcomes
5.1 Intraoperative pain
Comparisons of CSA with pethidine versus CSA with pethidine
plus piroxicam show that women in the pethidine group were
more likely to report no pain and less likely to report intense pain
than women given intramuscular pethidine plus oral piroxicam or
oral piroxicam only (12% vs 0% vs 0%, and 0% vs 4% vs 31%,
respectively; P = 0.035; N = 58) (Ocal 2002).
Comparisons of CSA with midazolam plus fentanyl versus CSA
with propofol plus fentanyl yielded no evidence of a difference
between groups in pain reported during oocyte retrieval (37/40
(93%) vs 36/40 (90%) reported no pain, 2/40 (5%) vs 2/40 (5%)
reportedmild pain, and 1/40 (2.5%) vs 2/40 (5%) reported severe
pain; N = 316) (Ma 2008).
One study measured mean intraoperative pain at five-minute in-
tervals. CSAwith dexmedetomidine plus PCBwas associated with
significantly less intraoperative pain when compared with CS with
midazolam plus PCB at five minutes (MD on 0 to 10 VAS -0.74,
95% CI -1.48 to 0.00; N = 52; Analysis 5.1) and at 10 minutes
(MD on 0 to 10 VAS -0.90, 95% CI -1.64 to -0.16; N = 52;
Analysis 5.2), respectively. Data show no significant differences
in mean pain scores between the two groups at 15, 20, and 25
minutes during oocyte retrieval (Elnabtity 2017).
Target-controlled infusion (TCI) is a system that maintains a par-
ticular target plasma drug concentration via standard pharmacoki-
netic equations. Comparison of different doses of TCI yielded no
evidence of a difference in pain between the three groups (TCI
with remifentanil 1.5 ng/mL, 2 ng/mL, and 2.5 ng/mL, respec-
tively) after the first puncture at five minutes (mean pain score on
a 10-point scale 0.7 (SD 0.3) vs 0.29 (SD 0.17) vs 0.35 (SD 0.19))
or at 10 minutes (1 (SD 1) vs 0.3 (SD 0.36) vs 0.28 (SD 0.28),
respectively; N = 69) or at 15 and 20 minutes (mean pain score
0.57 (SD 0.57) vs 0 (SD 0) vs 0.11 (SD 0.11) and 2 (SD 0) vs 0
(SD 0) vs 0 (SD 0), respectively; N = 69). Data show no evidence
of differences in pain between the three groups at completion of
the procedure (mean pain score 0.13 (SD 0.1) vs 0.09 (SD 0.09)
vs 0 (SD 0), respectively; N = 69) (Coskun 2011).
5.2 Postoperative pain
CSA with dexmedetomidine plus PCB was associated with less
pain than CSA with midazolam plus PCB at 20 minutes postop-
eratively (MD on 0 to 10 VAS 0.42, 95% CI -0.04 to 0.88; N
= 52; Analysis 5.3). Data show no significant difference in mean
pain scores between the two groups at 40 and 60 minutes postop-
eratively (Elnabtity 2017).
Secondary outcomes
5.3 Live birth rate and ongoing pregnancy rate
This outcome was not reported.
5.4 Clinical pregnancy rate
When researchers compared different doses of TCI (remifentanil
1.5 ng/mL, 2 ng/mL, and 2.5 ng/mL respectively), they found no
evidence of a difference in pain between the three groups and no
evidence of a difference in pregnancy rate between the three groups
(10/23 (43%) vs 10/23 (43%) vs 12/23 (52%), respectively; N =
69) (Coskun 2011).
Pregnancy rates per embryo transfer were similar with CSA with
dexmedetomidine plus PCB and CSA with midazolam plus PCB
(10/26 (38.4%) vs 10/26 (38.4%)) (Elnabtity 2017).
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5.5 Fertilisation rate
This outcome was not reported.
5.6 Abandoned procedure of oocyte retrieval
This outcome was not reported.
5.7 Side effects of analgesia
When investigators compared CSA with midazolam plus fentanyl
versus CSA with propofol plus fentanyl, they found that mida-
zolam plus fentanyl was associated with less nausea and vomit-
ing (10/40 (25%) and 4/40 (10%) vs 13/40 (32.5%) and 11/40
(27.5%); P < 0.05, respectively; N = 316) (Ma 2008).
Comparisons of different doses of target-controlled CSA infusion
(remifentanil 1.5 ng/mL, 2 ng/mL, and 2.5 ng/mL respectively)
yielded no evidence of differences in reports of postoperative nau-
sea and vomiting between the three groups (0/23 (0%) vs 1/23
(4%) vs 2/23 (9%), respectively; N = 69) (Coskun 2011).
Postoperative side effects (nausea, vomiting, dizziness, restlessness,
and headache) were similar between CSA with dexmedetomidine
plus PCB and CSA with midazolam plus PCB groups (Elnabtity
2017).
5.8 Postoperative complications
Trialists comparing patient-controlled CSA with propofol versus
patient-controlled CSA with midazolam found that one partic-
ipant in the midazolam group became transiently unresponsive
and two women in the propofol group reported syncope (Cook
1993).
Researchers comparing different doses of target-controlled CSA
infusion (remifentanil 1.5 ng/mL, 2 ng/mL, and 2.5 ng/mL re-
spectively) reported that five women needed a jaw thrust followed
by brief periods of assisted masked ventilation (Coskun 2011).
5.9 Patient satisfaction
Comparison of patient-controlled CSA with propofol versus pa-
tient-controlled CSA with midazolam revealed that both groups
reported that they would like to be given the same drug again for
a future procedure (20/22 (91%) in the midazolam group vs 24/
25 (96%) in the propofol group) (OR 0.42, 95% CI 0.04 to 4.94;
N = 47; Analysis 5.4) (Cook 1993).
Patient satisfaction scores were significantly higher in the group
given CSA with dexmedetomidine plus PCB than in the group
given CSA with midazolam plus PCB (OR 3.07, 95% CI 0.98 to
9.59; N = 52; Analysis 5.4) (Elnabtity 2017).
Comparisons of different doses of target-controlled CSA infusion
(remifentanil 1.5 ng/mL, 2 ng/mL, and 2.5 ng/mL respectively)
revealed that 66 women (95%) who were free from postoperative
nausea and vomiting were satisfied with their care (Coskun 2011).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Conscious sedation and analgesia (CSA) compared with CSA + electro-acupuncture for women undergoing oocyte retrieval for assisted reproduction
Patient or population: women undergoing oocyte retrieval for assisted reproduct ion
Setting: assisted reproduct ion clinic
Intervention: conscious sedat ion and analgesia (CSA)
Comparison: CSA + electro-acupuncture
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with CSA + elec-
tro-acupuncture
Risk with CSA only
(95% CI)
Intraoperat ive pain Mean intraoperat ive
pain score in the com-
parison group was 2.9
points on a 0 to 10 VAS
Mean score in the CSA-
only group was 3 points
higher
(2.23 higher to 3.77
higher).
- 62
(1 RCT)
⊕©©©
VERY LOWa,b
Postoperat ive pain Mean postoper-
at ive pain score in the
comparison group was
1.1 on a 0 to 10 VAS
Mean score in the CSA-
only group was 2.1
points higher
(1.4 higher to 2.8
higher).
- 61
(1 RCT)
⊕©©©
VERY LOWa,b
Pregnancy 594 per 1000 243 per 1000
(95 to 491)
OR 0.22
(0.07 to 0.66)
61
(1 RCT)
⊕©©©
VERY LOWa,b
Patient sat isfact ion No studies reported this outcome. Not est imable - -
Side ef fects (postoper-
at ive vomit ing and/ or
vomit ing)
218 per 1000 233 per 1000
(97 to 624)
OR 1.09
(0.33 to 3.58)
62
(1 RCT)
⊕©©©
VERY LOWa,b
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Postoperat ive compli-
cat ions
Airway obstruct ion: No studies reported this out-
come.
Not est imable - -
Need for mask vent ilat ion: No studies reported
this outcome.
Not est imable - -
*The risk in the intervention group (and its 95% conf idence interval) is based on the risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; OR: odds rat io; VAS: visual analogue scale
GRADE Working Group grades of evidence.
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded one level for serious risk of bias: unclear risk of bias in one or two domains.
bDowngraded two levels for very serious imprecision: very small sample size and event rate.
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Conscious sedation and analgesia (CSA) compared to general analgesia for women undergoing oocyte retrieval for assisted reproduction
Patient or population: women undergoing oocyte retrieval for assisted reproduct ion
Setting: assisted reproduct ion clinic
Intervention: conscious sedat ion and analgesia
Comparison: general analgesia (GA)
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with GA Risk with CSA only
(95% CI)
Intraoperat ive pain No studies reported this outcome. Not est imable - -
Postoperat ive pain Mean postoperat ive
pain score in the com-
parison group was 2.1
points on a 0 to 3 Likert
scale
Mean score in the CSA-
only group was 1.9
points lower
(2.24 lower to 1.56
lower).
- 50
(1 RCT)
⊕©©©
VERY LOWa,b
Pregnancy 278 per 1000 278 per 1000
(142 to 475)
OR 1.00
(0.43 to 2.35)
108
(2 RCTs)
⊕©©©
VERY LOWa,b
Patient sat isfact ion (re-
port of ’sat isfactory’)
981 per 1000 972 per 1000
(854 to 995)
OR 0.66
(0.11 to 4.04)
108
(2 RCTs)
⊕©©©
VERY LOWa,b
Side ef fects (postoper-
at ive vomit ing and/ or
vomit ing)
160 per 1000 81 per 1000
(15 to 344)
OR 0.46
(0.08 to 2.75)
50
(1 RCT)
⊕©©©
VERY LOWa,b
Postoperat ive compli-
cat ions
Airway obstruct ion: 207
per 1000
35 per 1000
(5 to 241)
OR 0.14
(0.02 to 1.22)
58
(1 RCT)
⊕©©©
VERY LOWa,b
Need for mask vent ila-
t ion: 793 per 1000
161 per 1000
(37 to 434)
OR 0.05
(0.01 to 0.20)
58
(1 RCT)
⊕©©©
VERY LOWa,b
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*The risk in the intervention group (and its 95% conf idence interval) is based on the risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial
GRADE Working Group grades of evidence.
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded two levels for very serious imprecision: very small sample size and event rate and/ or wide conf idence intervals
compatible with benef it in either group or no ef fect.
bDowngraded one level for serious risk of bias: unclear risk of bias in one or two domains.
2
7
P
a
in
re
lie
f
fo
r
w
o
m
e
n
u
n
d
e
rg
o
in
g
o
o
c
y
te
re
trie
v
a
l
fo
r
a
ssiste
d
re
p
ro
d
u
c
tio
n
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
8
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
Conscious sedation and analgesia (CSA) plus PCB compared with electro-acupuncture plus PCB for women undergoing oocyte retrieval for assisted reproduction
Patient or population: women undergoing oocyte retrieval for assisted reproduct ion
Setting: assisted reproduct ion clinic
Intervention: CSA + PCB
Comparison: electro-acupuncture + PCB
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with electro-
acupuncture + PCB
Risk with CSA + PCB
(95% CI)
Intraoperat ive pain Mean intraoperat ive
pain score in the com-
parison group was 2.6
to 4.85 points on a 0 to
10 VAS
Mean score in the CSA-
only group was 0.66
points lower
(0.93 lower to 0.39
lower).
- 781
(4 RCTs)
⊕⊕©©
LOWa,b
Postoperat ive pain No studies reported this outcome. Not est imable - -
Pregnancy 367 per 1000 358 per 1000
(295 to 428)
OR 0.96
(0.72 to 1.29)
783
(4 RCTs)
⊕⊕©©
LOWa,c
Patient sat isfact ion No studies reported this outcome. Not est imable - -
Side ef fects (postoper-
at ive vomit ing and/ or
vomit ing)
No studies reported this outcome. Not est imable - -
Postoperat ive compli-
cat ions
No studies reported this outcome. Not est imable - -
*The risk in the intervention group (and its 95% conf idence interval) is based on the risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; VAS: visual analogue scale
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GRADE Working Group grades of evidence.
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded one level for serious risk of bias: unclear risk of bias in one or two domains.
bDowngraded one level for serious inconsistency (I2 = 76%).
cDowngraded one level for serious imprecision: wide conf idence intervals compatible with benef it in either group or no ef fect.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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Conscious sedation and analgesia (CSA) plus paracervical block (PCB) compared with general anaesthetic (GA) for women undergoing oocyte retrieval for assisted
reproduction
Patient or population: women undergoing oocyte retrieval for assisted reproduct ion
Setting: assisted reproduct ion clinic
Intervention: CSA + PCB
Comparison: GA
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with GA Risk with CSA + PCB
(95% CI)
Intraoperat ive pain
Postoperat ive pain Mean postoperat ive
pain score in the com-
parison group was 0.68
points on a 0 to 10 VAS
Mean score in the CSA-
only group was 0.49
points higher
(0.13 lower to 1.11
higher).
- 50
(1 RCT)
⊕©©©
VERY LOWa,b
Pregnancy 375 per 1000 296 per 1000
(117 to 576)
OR 0.70
(0.22 to 2.26)
51
(1 RCT)
⊕©©©
VERY LOWa,b
Patient sat isfact ion No studies reported this outcome. Not est imable - -
Postoperat ive compli-
cat ions
No studies reported this outcome. Not est imable - -
*The risk in the intervention group (and its 95% conf idence interval) is based on the risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; VAS: visual analogue scale
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GRADE Working Group grades of evidence.
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded one level for serious risk of bias: unclear risk of bias in one or two domains.
bDowngraded two levels for very serious imprecision: small sample size and low event rate, wide conf idence intervals
compatible with benef it in either group or no ef fect.
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Conscious sedation and analgesia (CSA) plus paracervical block (PCB) compared with spinal anaesthesia for women undergoing oocyte retrieval for assisted reproduction
Patient or population: women undergoing oocyte retrieval for assisted reproduct ion
Setting: assisted reproduct ion clinic
Intervention: CSA + PCB
Comparison: spinal anaesthesia
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with spinal anaes-
thesia
Risk with CSA + PCB
(95% CI)
Intraoperat ive pain No studies reported this outcome. Not est imable - -
Postoperat ive pain Mean postoperat ive
pain score in the com-
parison group was 0.15
on a 0 to 10 VAS,
Mean score in the CSA-
only group was 1.02
points higher
(0.48 higher to lower to
1.56 higher).
- 36
(1 RCT)
⊕©©©
VERY LOWa,b
Pregnancy 375 per 1000 358 per 1000
(126 to 687)
OR 0.93
(0.24 to 3.65)
38
(1 RCT)
⊕©©©
VERY LOWa,b
Patient sat isfact ion No studies reported this outcome. Not est imable - -
Side ef fects (postoper-
at ive vomit ing and/ or
vomit ing)
No studies reported this outcome. Not est imable - -
Postoperat ive compli-
cat ions
No studies reported this outcome. Not est imable - -
*The risk in the intervention group (and its 95% conf idence interval) is based on the risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; VAS: visual analogue scale
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GRADE Working Group grades of evidence.
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded one level for serious risk of bias: unclear risk of bias in one or two domains.
bDowngraded two levels for very serious imprecision: very small sample size and low event rate, wide conf idence intervals
compatible with benef it in either group or no ef fect.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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Conscious sedation and analgesia (CSA) plus paracervical block (PCB) compared with PCB only for women undergoing oocyte retrieval for assisted reproduction
Patient or population: women undergoing oocyte retrieval for assisted reproduct ion
Setting: assisted reproduct ion clinic
Intervention: CSA + PCB
Comparison: PCB only
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with PCB only Risk with CSA + PCB
(95% CI)
Intraoperat ive pain No studies reported this outcome. Not est imable - - -
Postoperat ive pain No studies reported this outcome. Not est imable - - -
Pregnancy 253 per 1000 240 per 1000
(130 to 399)
OR 0.93
(0.44 to 1.96)
150
(1 RCT)
⊕⊕©©
LOWa
Patient sat isfact ion 800 per 1000 867 per 1000 OR 1.63
(0.68 to 3.89)
150
(1 RCT)
⊕⊕©©
LOWa
Side ef fects (postoper-
at ive vomit ing and/ or
vomit ing)
No studies reported this outcome Not est imable - -
Postoperat ive compli-
cat ions
No studies reported this outcome Not est imable - -
*The risk in the intervention group (and its 95% conf idence interval) is based on the risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial
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GRADE Working Group grades of evidence.
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded two levels for very serious imprecision: low event rates and wide conf idence intervals compatible with benef it
in either group or no ef fect.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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Conscious sedation and analgesia (CSA) plus paracervical block (PCB) compared with CSA alone
Patient or population: women undergoing oocyte retrieval for assisted reproduct ion
Setting: assisted reproduct ion clinic
Intervention: CSA + PCB
Comparison: CSA alone
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with CSA alone Risk with CSA + PCB
(95% CI)
Intraoperat ive pain No studies reported this outcome. Not est imable - -
Postoperat ive pain No studies reported this outcome. Not est imable - -
Pregnancy 600 per 1000 482 per 1000
(296 to 671)
OR 0.62
(0.28 to 1.36)
100
(1 RCT)
⊕©©©
VERY LOWa,b
Patient sat isfact ion No studies reported this outcome. Not est imable - -
Side ef fects (postoper-
at ive vomit ing and/ or
vomit ing)
300 per 1000 153 per 1000
(72 to 294)
OR 0.42
(0.18 to 0.97)
140
(2 RCTs)
⊕©©©
VERY LOWa,b
Postoperat ive compli-
cat ions
No studies reported this outcome. Not est imable - -
*The risk in the intervention group (and its 95% conf idence interval) is based on the risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial
GRADE Working Group grades of evidence.
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
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Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aDowngraded one level for serious risk of bias: unclear risk of bias in one or two domains.
bDowngraded two levels for very serious imprecision: small sample size, very low event rates, and wide conf idence intervals
compatible with benef it in the CSA + PCB group or with no meaningful ef fect.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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D I S C U S S I O N
Summary of main results
This review included 24 trials examining five broad categories of
pain relief methods of conscious sedation and analgesia that in-
volved 3160 women undergoing oocyte retrieval.Women’s experi-
ence of pain showed conflicting results. No one particular modal-
ity of conscious sedation and analgesia was better than any other
in providing effective pain relief. However, use of more than one
method simultaneously, as when combined with acupuncture or
paracervical block, resulted in better pain relief. Patient-controlled
sedation and analgesia was associated with greater intraoperative
pain thanwas physician-administered sedation and analgesia. Nei-
ther of these methods appeared to affect pregnancy rates. How-
ever, confidence intervals were wide in most comparisons; there-
fore these results should be interpreted with caution. Fifteen stud-
ies reported high levels of satisfaction in both intervention and
comparison groups.
The procedure of oocyte retrieval is painful, as has been demon-
strated by higher pain scores among women receiving placebo in
Ramsewak 1990 and lower pain scores associated with the inter-
vention. Regardless of the nature of the drug or the dose used,
opiates such as fentanyl were effective in reducing the perception
of pain. Addition to the opiate of a second drug or intervention,
such as paracervical block (PCB), conferred further benefit. The
principle of a balanced multi-modal approach to analgesia has
been shown to be effective for treating individuals with pain in
other clinical settings such as cancer (World Health Organiza-
tion (WHO) pain ladder; http://www.who.int/cancer/palliative/
painladder/en/) (accessed 10 July 2017).
Paracervical block reduced abdominal pain during oocyte retrieval
(Ng 1999); this was also demonstrated in a trial that reported
higher pain scores in a placebo plus PCBgroup (Ng 2001). In trials
evaluating PCB, women who were given additional intravenous
fentanyl reported lower intraoperative pain scores. Meta-analysis
of the intraoperative pain scores associated with intravenous fen-
tanyl plus PCB versus electro-acupuncture plus PCB favoured in-
travenous fentanyl. However, in these two studies, the group given
fentanyl also received premedication, whereas the group under-
going electro-acupuncture received no premedication (Gejervall
2005; Humaidan 2004).
Two studies administered additional analgesia as needed during
oocyte retrieval (Cook 1993; Gejervall 2005). One study inves-
tigated the dose-effect relationship of target-controlled infusion
(TCI) of remifentanil and propofol. TCI is a system thatmaintains
a particular target plasma drug concentration via standard phar-
macokinetic equations. This study described the need to ’adjust’
the dosage of the analgesic agent by increasing or decreasing the
dosage (Coskun 2011). This is likely to have caused some women
to change treatment groups, accounting for an important limita-
tion in reporting of pain based on the allocated intervention.
Women who received conscious sedation and analgesia combined
with electro-acupuncture reported less pain than women who re-
ceived conscious sedation and analgesia only (Meng 2008; Meng
2009; Sator-Katzenschlager 2006). However, the overall result is
inconclusive, as pooled data from four trials show that the pain
score was higher among women who received auricular electro-
acupuncture and PCB than among women given conscious se-
dation and analgesia with PCB only (Gejervall 2005; Humaidan
2004; Stener-Victorin 1999; Stener-Victorin 2003).
Five trials evaluated the effect of conscious sedation plus acupunc-
ture or electro-acupuncture on pregnancy rate; the result was in-
conclusive. Evidence on live birth rate, based on the findings of
one small trial, was also inconclusive (Stener-Victorin 1999).
Several trials (15 out of 24) reported insufficient evidence upon
comparison of rates of postoperative nausea and vomiting in the
two groups. A trial that compared propofol and midazolam in the
context of patient-controlled sedation and analgesia reported that
two women in the propofol group were unable to complete the as-
sessment after completion of the procedure. One was emotionally
upset by a difficult oocyte retrieval, and the other fainted upon sit-
ting up. One woman in the midazolam group became transiently
unresponsive intraoperatively when given rescue alfentanil by the
anaesthetist (Cook 1993). Onewoman in the PCS via inhalational
isodesox group needed perioperative airway support (Thompson
2000). Two women had perforation and one had vaginal bleeding
after completion of the procedure (group not reported) (Guasch
2005). In another study, five women needed brief periods of as-
sisted mask ventilation (Coskun 2011). The remaining reviewed
trials documented no other serious adverse effects or cancellations
of the oocyte retrieval procedure. It is unclear whether no adverse
effects actually occurred, or whether these effects were simply un-
reported.
Patient satisfaction was high with all modalities of conscious seda-
tion and analgesia that were reviewed. No one particular method
or delivery system appeared to be clearly better than the other,
although use of one method simultaneously with acupuncture or
paracervical block resulted in better pain relief than was attained
by use of one modality alone. In choosing conscious sedation and
analgesia for oocyte retrieval, a balance may need to be struck
between effectiveness, safety, and availability of resources. In this
update, two studies measured women’s satisfaction as well as their
well-being (fear, stress, and anxiety), and this provided some in-
dication of the quality of women’s experiences (Gejervall 2005;
Sator-Katzenschlager 2006).
It is unclear whether global satisfaction can be regarded as a mean-
ingful outcome in determining the effectiveness of the nature,
dose, and delivery system of sedation and analgesia used for oocyte
retrieval. It is possible that the overall success of the operative pro-
cedure (in terms of oocytes collected) and anxiety about side ef-
fects of drugs may override any distress caused by the pain. The
effectiveness and adequacy of sedation and analgesia, important
as they are, may not be the most important outcomes for women
38Pain relief for women undergoing oocyte retrieval for assisted reproduction (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
undergoing oocyte retrieval when compared with the satisfaction
related to a good (or bad) experience of this painful but short and
stressful procedure. When patient-controlled analgesia was used,
patients pressed the demand button only when the pain became
intolerable (Chumbley 1998). It has also been reported that some
patients were reluctant to eliminate pain completely, even when
encouraged to do so (Hawkins 1993). The generally high satis-
faction levels may reflect the fact that the overall success of the
procedure had the potential to counteract the discomfort of the
procedure.
In this review, most of the mean differences in pain on a visual
analogue scale (VAS) (0 to 10) between different CSA methods
were below 2.0, but a few exceeded 2.0, which we believe could
represent a clinically important difference.However, tolerance and
the experience of pain varied among individuals, making it diffi-
cult to interpret the findings of this outcome. General anaesthesia
would eliminate pain altogether but is likely to have cost impli-
cations. For women who wish to avoid pharmacological analgesia
and the side effects of opiates, general anaesthesia, or any agent,
electro-acupuncture may be an effective alternative, depending on
the resources available. The ideal regimen of conscious sedation
and analgesia would reduce pain to a tolerable level in all patients
without risk of adverse respiratory or cardiovascular events. This
review demonstrates the variety of approaches available to achieve
this and underlines the difficulty of identifying the most superior
method(s).
Overall completeness and applicability of
evidence
We identified five main interventions comprising 14 dissimilar
comparisons, with little consistency in the choice of outcomes.
Intraoperative pain was reported in 22 studies, and 11 studies re-
ported the outcome of only postoperative pain. Even when similar
drugs were used, routes of administration and doses varied widely.
Use of complex interventions inmany trials impaired our ability to
assess the effects of individual pain relief measures. When pain was
the chosen outcome, data show marked differences in the timing
of pain assessment and the measuring instruments used, which in-
cluded the visual analogue scale (VAS), the Likert scale, and other
numerical and non-numerical rating scales. Although it is clear
that intraoperative pain was measured during oocyte retrieval, the
definition of postoperative pain ranged from pain immediately af-
ter oocyte retrieval (end of procedure) to time periods (minutes or
hours) following oocyte retrieval. This ambiguity is likely to influ-
ence the applicability of the evidence on pain relief. Heterogeneity
in the wide range of interventions, dosing regimens, and outcome
measures limited our ability to aggregate data meaningfully and
to generate conclusions. The subjective nature of pain and satis-
faction and the different measures used to assess them limit our
ability to interpret and aggregate these outcomes satisfactorily.
In many of the studies reviewed, it is not clear whether pain was
measured retrospectively. It is also impossible to ascertain whether
a low pain score was due to the increased efficacy of intravenous
fentanyl, or whether the premedication altered pain perception or
interfered with a person’s ability to report the experience of pain.
Co-interventions such as premedication might distort the mem-
ory of pain. This must be taken into account in interpreting data
from trials that measured pain retrospectively and highlights the
difficulty of disentangling the individual anxiolytic, sedative, and
analgesic effects of a sedative-analgesic combination. For exam-
ple, analgesics such as fentanyl and pethidine in high dosages can
produce sedation, and intravenous anaesthetics such as propofol
(sedative and analgesic) can have sedative effects at subanaesthetic
dosages.
Measuring intraoperative pain would not be possible in two of the
trials that used general anaesthesia as a comparator (Ben-Shlomo
1999; Guasch 2005). Unlike the combination of midazolam and
ketamine (Ben-Shlomo 1999), short-acting fentanyl may lack ad-
equate residual analgesic effect to provide postoperative pain re-
lief. The amnesic effect of midazolam may be an important con-
founder, as it can potentially obliterate the memory of pain. Pethi-
dine was reported to be a more effective pain relief agent than
piroxicam (Ocal 2002), a non-steroidal anti-inflammatory drug.
Comparison of the delivery system and the actual agents used in
Bhattacharya 1997, Lier 2014, Lok 2002, Thompson 2000, and
Zelcer 1992 shows that the validity of the comparison could be af-
fected in trials of patient-controlled sedation and analgesia (PCS).
Although the theoretical advantage of PCS is that it allows women
to administer as much pain relief as they need, this advantage may
be limited by (1) the way the pump is set up to deliver a me-
tered dose, and (2) a built-in lockout time for reasons of safety.
A physician may anticipate painful episodes and may give a dose
larger than a PCS pump would permit. Meta-analysis of the in-
traoperative pain score between patient-controlled and physician-
administered sedation and analgesia shows that less pain was expe-
rienced by patients in the physician-controlled group. However,
this finding must be interpreted with caution in the light of differ-
ent sedative and analgesic agents and dosages used in these trials.
Quality of the evidence
Using GRADE methods, review authors assessed evidence to be
generally of lowor very lowquality,mainly owing topoor reporting
and imprecision.
Risk of bias in the included trials varied. Six trials did not report
the method of randomisation used. Methods of allocation con-
cealment were unclear in nine studies, which were at unclear risk
of bias. Attempts to contact trial authors by email and letter for
clarificationmetwith limited success. Seven trials did not carry out
intention-to-treat analyses. Overall the sample size ranged from
30 to 700 women. To attain 80% power of detecting a difference
of 7 mm on the VAS at the 5% significance level, a minimum of
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70 women would be needed. Thirteen trials did not report sam-
ple size calculation. Although blinding of women was not feasi-
ble owing to the nature of the interventions (such as patient-con-
trolled sedation and analgesia vs physician-administered sedation
and analgesia), five trials reported blinding of participants and six
reported blinding of outcome assessors, which is essential in prin-
ciple to minimise measurement bias. Figure 1 and Figure 2 show
the review authors’ judgements about risk of bias among the trials
included in this review.
Potential biases in the review process
We did not exclude studies on the grounds of language. However,
some bias in the review process may have arisen from inclusion
of trials with insufficient information or outcome data and from
lack of response of trial authors to our enquiries.
Agreements and disagreements with other
studies or reviews
A systematic review of pain relief in oocyte retrieval restricted itself
to trials comparing electro-acupuncture versus other conscious
sedation methods (Stener-Victorin 2005). The findings of that
review were similar to our findings in this population.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Evidence does not support one particular method or technique
over another for providing effective conscious sedation and anal-
gesia for pain relief during and after oocyte retrieval. Simultaneous
use of sedation combined with analgesia such as the opiates, fur-
ther enhanced by paracervical block or acupuncture techniques,
resulted in better pain relief than was attained by one modality
alone. Evidence was insufficient to show conclusively whether any
of the interventions provided influenced pregnancy rates. All re-
viewed techniqueswere associatedwith a high degree of patient sat-
isfaction. Women’s preferences and resource availability for choice
of pain relief merit consideration in practice.
Implications for research
One of the limitations of previous research has been the diversity
of methods available to provide conscious sedation and analge-
sia, as well as lack of standardisation of measures used to assess
outcomes of pain and satisfaction. This limitation renders com-
parison across trials difficult and aggregation of data impossible.
In planning future research, greater consensus is needed to deter-
mine both the tools to be used to evaluate pain and the timing
of pain evaluation during and after the procedure. Postoperative
pain should bemonitored after discharge and until readmission for
embryo transfer, so researchers can assess whether recovery from
postoperative pain is sufficiently quick. Pain assessment based on
both subjective and objective measures merits consideration. In
addition, future trials should explore women’s views on how in-
dividualised analgesic support can best be provided during oocyte
retrieval.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ben-Shlomo 1999
Methods Randomisation: random numbers
Allocation concealment: sealed in consecutive envelopes
Blinding of participants/investigators: no
Blinding of assessors: no
No. randomised: 50
No. analysed: 50
Intention-to-treat analysis: yes
Power and sample calculations not described
Duration of trial: not stated
Participants Women scheduled for oocyte retrieval
Mean age: 34 years; cause of infertility not reported
Similar baseline characteristics of age, height, and weight
Interventions 1. Control: conscious sedation and analgesia with IV midazolam 0.06 mg followed
after 2 minutes by ketamine 0.75 mg/kg (N = 25)
2. Intervention: general anaesthesia with IV fentanyl 0.017 mg/kg followed after 2
minutes by IV propofol 2.5 mg/kg (N = 25)
No premedication in either group
Outcomes 1. Primary: postoperative pain (Likert scale 0 to 3; 0 = none; 3 = severe)
2. Secondary: clinical pregnancy rate, fertilisation rate, satisfaction (Likert scale 0 to
3)
Other outcomes reported: no. of oocytes retrieved, cleavage rate, arousability, response
to painful stimuli
Notes Israel
Single centre
HaEmek Mecical Centre
Funding: not stated
Definition of pregnancy not documented
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random numbers
Allocation concealment (selection bias) Low risk Adequate: sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible because of the nature
of the interventions
Blinding of assessors not reported
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Ben-Shlomo 1999 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent dropout
Selective reporting (reporting bias) Low risk All pre-stated outcomes reported
Other bias Unclear risk Comparable baseline characteristics of age,
height, and weight but not cause of infer-
tility
Bhattacharya 1997
Methods Randomisation: computer-generated random numbers
Allocation concealment: sealed in consecutively numbered envelopes
Blinding of participants/investigators: no
Blinding of assessors: no
No. randomised: 81
No. analysed: 81
Intention-to-treat analysis: yes
Power and sample calculations described
Duration of trial: not stated
Participants Women undergoing vaginal oocyte recovery
Mean age: 33 years
Mean duration of infertility 5.5 years; 26% tubal disease
Similar baseline demographic and infertility characteristics
Interventions 1. Control: patient-controlled sedation and analgesia (IV fentanyl 200 µg) via
patient-controlled sedation and analgesia (PCS) machine (N = 39)
2. Intervention: intermittent physician-administered sedation and analgesia (PAS)
(IV fentanyl 200 µg) (N = 42)
All women received a preliminary IV loading dose of midazolam 4 mg
Outcomes 1. Primary: intraoperative pain score (VAS 1 to 100)
2. Secondary: patient satisfaction
Other outcomes reported: perioperative blood pressure, pulse, oxygen, doses of fentanyl
Notes Scotland
Single centre
Aberdeen University
Funding: not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation
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Bhattacharya 1997 (Continued)
Allocation concealment (selection bias) Low risk Adequate: sealed numbered envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible because of the nature
of the interventions
Blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
Cook 1993
Methods Randomisation: method unclear
Allocation concealment: sealed envelopes
Blinding of participants/investigators: no
Blinding of assessors: yes
No. randomised: 47
No. analysed: 47
Intention-to-treat analysis: yes
Power and sample calculations: not reported
Duration of trial: not stated
Participants Women presenting for transvaginal oocyte retrieval
Mean age and weight similar in both groups (no data given)
Cause of infertility: not reported
Comparison of baseline characteristics: age/weight only
Interventions 1. Control: patient-controlled sedation and analgesia infusion (propofol 300 mg in
30 mL) via a pump (N = 25)
2. Intervention: patient-controlled sedation and analgesia infusion (midazolam 300
mg in 30 mL) via a pump (N = 22)
IV alfentanil administered at 3 points: before insertion of vaginal speculum, before needle
entry into each ovary, on request
Outcomes Secondary: patient satisfaction (VAS), adverse outcomes
Other outcomes reported: sedation levels, psychometric tests
Notes England
Single centre
London University
Funding: not stated
Risk of bias
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Cook 1993 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Methods unclear
Allocation concealment (selection bias) Low risk Adequate, sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not feasible because of the differ-
ent appearance of drugs
Assessors blind
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Unclear risk Comparable baseline characteristics of age
and weight but not cause of infertility
Coskun 2011
Methods Randomisation: computer-generated
Allocation concealment: quote “enclosed” numbers
Blinding of participants/investigators: no
Blinding of assessors: yes (for postop side effects)
No. randomised: 69
No. analysed: 69
Intention-to-treat analysis: yes
Power and sample calculations: described
Duration of trial: not stated
Participants Women scheduled for transvaginal oocyte retrieval
Mean age: 33 to 35 years
Cause of infertility: not reported
Comparison of baseline characteristics: age, weight, and height only
Similar demographic characteristics at baseline
Interventions 1. Control: TCI (target-controlled infusion) propofol 1% plus remifentanil 1.5 ng/
mL (N = 23)
2. Intervention I: TCI propofol 1% plus remifentanil 2 ng/mL (N = 23)
3. Intervention II: TCI propofol 1% plus remifentanil 2.5 ng/mL (N = 23)
TCI = A system thatmaintains a particular target plasma drug concentration via standard
pharmacokinetic equations
Outcomes 1. Primary: intraoperative pain score (0 to 10-point numerical rating scale)
2. Secondary: pregnancy rate, side effects, satisfaction
Other outcomes reported: sedation score, amount of sedation required, recovery score,
blood pressure
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Coskun 2011 (Continued)
Notes Turkey
Single centre
Gazi University
Funding: not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation
Allocation concealment (selection bias) Low risk Quote “enclosed” numbers
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not reported
Blinding of assessors for postop side effects
only
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Unclear risk Comparable baseline characteristics of age,
height, and weight but not cause of infer-
tility
Elnabtity 2017
Methods Ransomisation: method unclear
Allocation concealment: serially numbered, sealed opaque envelopes
Blinding of participants/investigators: yes
Blinding of assessors: not reported
No. randomised: 52
No. analysed: 52
Intention-to-treat analysis: awaiting response from trial author
Power and sample calculations described
Duration of trial: from September 2014 to April 2015
Participants Women with ASA I/II undergoing ultrasound-guided oocyte retrieval in an IVF pro-
gramme
Mean age: 25 to 38 years
Cause of infertility: tubal disease, endometriosis, anovulation, male factor, unexplained
Similar demographic (age, height, weight, BMI) and infertility characteristics at baseline
Inclusion criteria: women in their first IVF cycle and showing bilateral ovarian follicular
response
Exclusion criteria: psychological abnormalities; cardiorespiratory, renal, or liver disease;
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Elnabtity 2017 (Continued)
requesting general anaesthesia; fewer than 3 dominant follicles present in either ovary;
chronic alcohol/drug abusers; allergic to any of the medications used in the study
Interventions 1. Intervention 1: IV fentanyl (1 µg/kg) plus paracervical block (100 mg lidocaine 1%)
plus IV dexmedetomidine (1 µg/kg) (N = 26)
2. Intervention 2: IV fentanyl (1 µg/kg) plus paracervical block (100 mg lidocaine 1%)
plus IV midazolam (0.06 mg/kg) (N = 26)
Outcomes 1. Primary: intraoperative and postoperative pain scores (VAS 0 to 100)
2. Secondary: pregnancy rate per embryo transfer, side effects of analgesia, postop
complications, patient satisfaction (Likert scale)
Other outcomes reported: intraoperative vital signs, no. of oocytes obtained, embryos
transferred per woman, amount of rescue propofol used
Notes Egypt
University Hospital
No funding received
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method unclear
Allocation concealment (selection bias) Low risk Adequate: serially numbered and sealed
opaque envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Double-blind (investigators and partici-
pants)
Blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No losses to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
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Gejervall 2005
Methods Randomisation: computer-generated list
Allocation concealment: unclear
Blinding of participants/investigators: yes
Blinding of assessors: yes
No. randomised: 160
No. analysed: 158
Intention-to-treat analysis: reported both as intention-to-treat and ‘as per protocol’
Power and sample calculations described
Duration of trial: 19 months, from March 2002 to October 2003
Participants Women undergoing oocyte aspiration
Mean age: 33 to 34 years (range 23 to 39 years)
Cause of infertility: tubal factor, hormonal factor, endometriosis, male factor, unex-
plained
Similar demographic and infertility characteristics at baseline
Interventions In a 1:1 ratio,
1. Control: conventional sedation and analgesia (IV alfentanil 0.5 mg) plus
paracervical block (lidocaine 0.5%) (N = 80)
2. Intervention: electro-acupuncture plus paracervical block (lidocaine 0.5%) (N =
80)
Control group received premedication (oral flunitrazepam 0.5mg and rectal paracetamol
1 g); EA group did not receive premedication
Outcomes 1. Primary: intraoperative and postoperative pain scores (VAS 0 to 100)
2. Secondary: pregnancy rate, patient satisfaction (VAS 0 to 100)
Other outcomes reported: well-being, number of embryos transferred, pregnancy per
cycle
Notes Sweden
Single centre
University Hospital Goteborg
Funding: Research & Development Council, Goteborg and Bohuslan, the Hjarmar
Sevensson Foundation, the Organon Foundation, the Wilhelm & Marina Lundgren’s
Foundation
Loss to follow-up (N = 2) in intervention group due to ovulation before aspiration and
missing VAS assessment
Definition of pregnancy not documented
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer randomisation
Allocation concealment (selection bias) Unclear risk Methods unclear
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Gejervall 2005 (Continued)
Blinding (performance bias and detection
bias)
All outcomes
Low risk Blinding of participants not feasible owing
to the nature of the intervention
Personwho assessed theVAS blinded to the
groups to which participants belonged
Other midwives not involved in adminis-
tering EA assisted in the analgesia proce-
dure during oocyte retrieval
Incomplete outcome data (attrition bias)
All outcomes
Low risk Two lost to follow-up. Data available for
intention-to-treat and ‘per protocol’
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
Guasch 2005
Methods Randomisation: computer generation
Allocation concealment: method unclear
Blinding of participants/investigators: no
Blinding of assessors: yes
No. randomised: 65
No. analysed: 65 (IVF outcomes); 45 (satisfaction)
Intention-to-treat analysis: yes for IVF outcomes, no for satisfaction outcomes
Power and sample calculations not reported
Duration of trial: 18 months, from March 1999 to September 2002
Participants Women undergoing oocyte retrieval
Age range 24 to 39 years
Cause of infertility: not reported
Similar baseline characteristics of age/height/weight
Interventions 1. Control: conscious sedation and analgesia (IV alfentanil 10 µg/kg −1 and
midazolam 0.06 mg/kg −1 plus paracervical block (lidocaine 1.5%)) (N = 24)
2. Intervention group 1: general anaesthesia (IV alfentanil 10 µg/kg −1) (N = 27)
3. Intervention group 2: spinal anaesthesia (N = 14)
No premedication given to any groups
Outcomes 1. Primary: intraoperative and postoperative pain (VAS 0 to 100)
2. Secondary: pregnancy rate, patient satisfaction (%), side effects, adverse effects
Other outcomes reported: serumprolactin levels, follicular cortisol levels, oocyte recovery
rate
Notes Spain
Single centre
Hospital Universitario La Paz, Madrid
Funding: not stated
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Guasch 2005 (Continued)
Definition of pregnancy not documented
Fourth group (non-randomised) receiving remifentanil: data not used for the review
Paper in Spanish
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation
Allocation concealment (selection bias) Unclear risk Methods unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible owing to the nature
of the interventions
Analysis conducted by an independent per-
son not involved in the trial
Oocyte and fertilisation data collected by a
blinded investigator
Incomplete outcome data (attrition bias)
All outcomes
Low risk Complete for pain but incomplete for sat-
isfaction
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Unclear risk Comparable baseline characteristics of age,
height, and weight but not cause of infer-
tility
Gunaydin 2007
Methods Randomisation: methods unclear
Allocation concealment: sealed envelopes
Blinding of participants/investigators: no
Blinding of assessors: no
No. randomised: 40
No. analysed: 40
Intention-to-treat analysis: yes
Power and sample calculations briefly described
Duration of trial: not stated
Participants Women scheduled to undergo transvaginal oocyte retrieval
Mean age: 32 to 33 years
Cause of infertility: not reported
Similar baseline characteristics of age, height, and weight
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Gunaydin 2007 (Continued)
Interventions 1. Control: conscious sedation and analgesia (IV remifentanil 2 mg in 20 mL saline)
(N = 20)
2. Intervention: conscious sedation and analgesia (IV remifentanil 2 mg in 20 mL
saline) and paracervical block (lidocaine 1%) (N = 20)
Outcomes 1. Primary: intraoperative pain score (visual numerical scale (VAS): 0 = no pain; 10 =
severe pain)
2. Secondary: side effects, patient satisfaction (good, moderate, or bad)
Other outcomes reported: plasma remifentanil levels, pulmonary function
Notes Turkey
Single centre
Gazi University
Funding: not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Methods unclear
Allocation concealment (selection bias) Low risk Closed envelope allocation
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Unclear risk Comparable baseline characteristics of age,
height, and weight but not cause of infer-
tility
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Humaidan 2004
Methods Randomisation: computer-generated
Allocation concealment: sealed unlabelled envelopes
Blinding of participants/investigators: no
Blinding of assessors: no
No. randomised: 200
No. analysed: 200
Intention-to-treat analysis: yes
Power and sample calculations described
Duration of trial: 9 months, from April to December 2002
Participants Women in IVF programme undergoing transvaginal oocyte retrieval
Mean age: 31 to 32 years (range 22 to 39)
Cause of infertility: male, tubal disease, endometriosis, anovulation, unexplained
Similar demographic and infertility characteristics at baseline
Interventions 1. Control: conscious sedation and analgesia (with IV alfentanil 0.25 mg) and
paracervical block (lidocaine 10 mL (5 mg/mL)) (N = 100)
2. Intervention: electro-acupuncture (EA) plus paracervical block (PCB) (N = 100)
Conscious sedation and analgesia group received premedication (oral benzodiazepine 10
mg); EA group did not
Outcomes 1. Primary: intraoperative and postoperative pain scores (VAS 0 to 100)
2. Secondary: pregnancy rate
Other outcomes reported: no. of cycles, no. of embryos transferred, implantation rate
Notes Denmark
Single centre
Skiive Hospital
Funding: not stated
Definition of pregnancy not documented
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated
Allocation concealment (selection bias) Low risk Adequate: sealed unlabelled envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible owing to the nature
of the interventions
Blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
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Humaidan 2004 (Continued)
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
Lier 2014
Methods Randomisation: computer-generated list
Allocation concealment: not reported
Blinding of participants/investigators: open-label design, study not blind to participants
nor to physicians and investigators
Blinding of assessors: open-label design, study not blind to participants nor to physicians
and investigators
No. randomised: 76
No. analysed: 76
Intention-to-treat analysis: yes
Power and sample calculations described
Duration of trial: 5 days after oocyte retrieval; duration of treatment: from 8 to 8.4
minutes
Participants Women who had an indication for IVF/intracytoplasmic sperm injection (ICSI)
Mean age: 35 ± 5 years
Mean BMI: 24 ± 4
Causes of infertility (primary, secondary, endometriosis): similar in both groups
IVF or ICSI: similar in both groups
No. of previous cycles: similar in both groups
Interventions 1. Control: patient-controlled analgesia with IV remifentanil (0.5 µg/kg per bolus) via a
pump; diclofenac suppository 50 mg given 30 minutes before remifentanil (N = 36)
2. Intervention: anaesthetist-administered standard pethidine therapywith IM pethidine
(2 mg/kg body weight) and midazolam (5 mg per os), given 30 minutes before oocyte
retrieval; no diclofenac suppository given (N = 40)
Both groups received atropine 0.5 mg IM 30 minutes before oocyte retrieval
Outcomes 1. Primary: intraoperative and postoperative pain via NRS (numeric rating scale)
2. Secondary: ongoing pregnancy rate, side effects of analgesia, postoperative complica-
tions, patient satisfaction
Notes The Netherlands
University Medical Centre
Funding: VUUniversityMedical Center (registered at theNetherlandsTrial Registration
(NTR 2431))
Pregnancy defined by positive foetal cardiac activity at 12 weeks’ gestation on ultrasound
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated
56Pain relief for women undergoing oocyte retrieval for assisted reproduction (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lier 2014 (Continued)
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Open-label design, not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
Lok 2002
Methods Randomisation: computer-generated
Allocation concealment: sealed opaque envelopes
Blinding of participants/investigators: no
Blinding of assessors: no
No. randomised: 110
No. analysed: 106
Intention-to-treat analysis: no
Power and sample calculations described
Duration of trial: not stated
Participants Women undergoing transvaginal oocyte retrieval
Mean age: 33 to 35 years
Cause of infertility: tubal disease, male factor, endometriosis, anovulation, unexplained
Women in control group 2 years younger than women in intervention group (P = 0.01)
; other baseline characteristics similar
Interventions 1. Control: patient-controlled sedation and analgesia (IV propofol 10 mg/mL and
alfentanil 40 mcg/mL) via a pump (N = 51)
2. Intervention: physician-administered sedation and analgesia with IV pethidine 1.
5 mg/kg 5 to 10 minutes before oocyte retrieval (N = 55); additional pethidine 0.5 mg/
kg given when necessary
No premedication in either group
Outcomes 1. Primary: intraoperative and postoperative pain scores (VAS 0 to 100)
2. Secondary: fertilisation, clinical pregnancy rate, patient satisfaction (VAS)
Notes China
Single centre
Chinese University of Hong Kong
Funding: not stated
Loss to follow-up (N = 4) in intervention group due to pump failure (n = 1) and personal
reasons (n = 3)
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Lok 2002 (Continued)
Definition of pregnancy not documented
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated
Allocation concealment (selection bias) Low risk Adequate: sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible owing to the nature
of the interventions
Blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Four lost to follow-up (3%)
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Unclear risk Significant differences in age between the
2 groups
Comparable infertility characteristics at
baseline
Ma 2008
Methods Randomisation: random numbers table
Allocation concealment: methods unclear
Blinding of participants/investigators: no
Blinding of assessors: no
No. randomised: 80
No. analysed: 80
Intention-to-treat analysis: yes
Power and sample calculations not described
Duration of trial: 8 months from February to September 2006
Participants Women undergoing oocyte retrieval
Mean age: 31 to 33 years
Cause of infertility: tubal disease, PCOS, endometriosis, male factor, unexplained
Similar demographic and infertility characteristics at baseline
Interventions 1. Control: conscious sedation and analgesia (iv midazolam combined with fentanyl
3.5 µg/kg) (N = 40)
2. Intervention: conscious sedation and analgesia (iv propofol combined with
fentanyl 3.5 µg/kg) (N = 40)
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Ma 2008 (Continued)
Outcomes 1. Primary: intraoperative pain score (minimal, moderate, and severe)
2. Secondary: side effects
Other outcomes reported: changes in blood pressure
Notes China
Single centre
Zhejiang University, Hangzhou, China
Funding: not stated
Paper in Chinese
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation table
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
Matsota 2012
Methods Randomisation: group allocation envelopes randomly selected by co-investigators (ad-
ditional information from trial author)
Allocation concealment: group allocations in sealed envelopes kept in locked office (ad-
ditional information from trial author)
Blinding of participants/investigators: no, owing to the nature of the intervention
Blinding of assessors: yes, assessors blind to group allocation (additional information
from trial author)
No. randomised: 58
No. analysed: 58
Intention-to-treat analysis: yes
Power and sample calculations not described
Duration of trial: not stated
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Matsota 2012 (Continued)
Participants Women scheduled for ultrasound transvaginal oocyte retrieval
Mean age 34 to 35.5 years
Mean body weight: 62 kg
Cause of infertility: 51 cases of primary infertility, 7 cases of secondary infertility
Similar demographic and infertility characteristics at baseline
Interventions 1. Control: conscious sedation/analgesia with remifentanil (a bolus dose 1 µg.kg −1 of
remifentanil administered slowly during 1minute following by a continuous IV infusion
at a rate of 0.15 to 0.4 µg.kg −1.min −1) (N = 29)
2. Intervention: general anaesthesia with IV propofol 2 mg.kg−1 and alfentanil 15 µg.
kg −1, maintained with propofol continuous infusion at a rate of 2 to 4 mg.kg −1.h −1
(N = 29).
All participants unpremedicated and received midazolam 2 mg IV just before start of
the procedure
Outcomes Secondary: clinical pregnancy rate, fertilisation rate, side effects, postoperative compli-
cations, patient satisfaction
Other outcomes reported: implantation and cleavage rates
Notes Greece
Single centre
University Hospital
Funding: not stated
Definition of pregnancy: over 16 weeks of gestation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Group allocation envelopes randomly se-
lected by co-investigators
Allocation concealment (selection bias) Low risk Group allocations in sealed envelopes kept
in locked office (additional information
from trial author)
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible owing to the nature
of the interventions
Blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
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Meng 2008
Methods Randomisation: random numbers table
Allocation concealment: method unclear
Blinding of participants/investigators: no
Blinding of assessors: no
No. randomised: 316
No. analysed: 316
Intention-to-treat analysis: yes
Power and sample calculations not reported
Duration of trial: 5 months, from March to July 2007
Participants Women undergoing transvaginal oocyte retrieval
Mean age: 31 years (23 to 46 years)
Cause of infertility: tubal disease, PCOS, endometriosis, male factor, unexplained
Similar demographic and infertility characteristics at baseline
Interventions 1. Control: conscious sedation and analgesia with IM pethidine (N = 170)
2. Intervention: conscious sedation and analgesia with IM pethidine plus electro-
acupuncture (N = 146)
Outcomes 1. Primary: intraoperative and postoperative pain scores (minimal, moderate, and
severe)
2. Secondary: side effects
Other outcomes reported: changes in pulse and blood pressure
Notes China
Single centre
Nanjing university of TCM
Funding: not stated
Paper in Chinese
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation table
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible owing to the nature
of the interventions
Assessors blinded to group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
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Meng 2008 (Continued)
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
Meng 2009
Methods Randomisation: random number table
Allocation concealment: methods unclear
Blinding of participants/investigators: no
Blinding of assessors: no
No. randomised: 700
No. analysed: 694
Intention-to-treat analysis: no
Power and sample calculations not reported
Duration of trial: 8 months, from June 2007 to January 2008
Participants Women undergoing transvaginal oocyte retrieval
Mean age: 30 to 31 years
Cause of infertility: not reported, duration of infertility < 5 years
Similar demographic and infertility characteristics at baseline
Interventions 1. Control: conscious sedation and analgesia (IM Dolantin 50 mg) (N = 353)
2. Intervention: conscious sedation and analgesia (IM Dolantin 50 mg) plus electro-
acupuncture (N = 347)
Outcomes Primary: pain (unclear whether intraoperative or postoperative) according to pain thresh-
olds
Notes China
Single centre
Nanjing University of TCM
Funding: not stated
No reason given for dropout (N = 6)
Paper in Chinese
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation table
Allocation concealment (selection bias) Unclear risk Not reported
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible owing to the nature
of the interventions
Blinding of assessors not reported
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Meng 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Six lost to follow-up (2 in control group; 4
in intervention group), no reason given
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
Ng 2001
Methods Randomisation: computer-generated
Allocation concealment: sealed envelopes
Blinding of participants/investigators: yes
Blinding of assessors: yes
No. randomised: 150
No. analysed: 150
Intention-to-treat analysis: yes
Power and sample calculations described
Duration of trial: not stated
Participants Women undergoing egg collection
Mean age: 35 years (range 27 to 43 years)
Cause of infertility: tuboperitoneal, male factor, endometriosis, unexplained
Similar demographic and infertility characteristics at baseline
Interventions 1. Control: conscious sedation and analgesia (placebo with normal saline) and PCB
(N = 75)
2. Intervention: conscious sedation and analgesia with (IV diazepam 5 mg and
pethidine 25 mg) and PCB (10 mL lidocaine; 1.5%) (N = 75)
Both groups received premedication (IM pethidine 50 mg and promethazine 25 mg)
Outcomes 1. Primary: intraoperative pain score (VAS 0 to 100)
2. Secondary: pregnancy rates, fertilisation, patient satisfaction (excellent,
satisfactory, fair, or unsatisfactory)
Other outcomes reported: no. of embryos transferred, implantation rate, multiple preg-
nancy rate
Notes China
Single centre
University of Hong Kong
Funding: not stated
Definition of pregnancy not documented
Risk of bias
Bias Authors’ judgement Support for judgement
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Ng 2001 (Continued)
Random sequence generation (selection
bias)
Low risk Computer-generated
Allocation concealment (selection bias) Low risk Adequate: sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
Low risk Both participant and doctor carrying out
the procedure were blind to the sedation
given
Nurses not involved in the Unit asked par-
ticipants about pain levels
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
Ocal 2002
Methods Randomisation: method unclear
Allocation concealment: method unclear
Blinding of participants/investigators: no
Blinding of assessors: no
No. randomised: 58
No. analysed: 58
Intention-to-treat analysis: yes
Power and sample calculations not reported
Duration of study: not stated
Participants Women admitted for vaginal oocyte retrieval
Mean age: 31 to 33 years (range 25 to 41 years)
Cause of infertility: not reported
Similar baseline characteristics of age
Interventions 1. Control: conscious sedation and analgesia (IM pethidine 50 mg) (N = 17)
2. Intervention I: conscious sedation and analgesia (IM pethidine 50 mg plus
piroksikam 20 mg orally) (N = 25)
3. Intervention II: conscious sedation and analgesia (IM piroksikam 20 mg) (N = 16)
Outcomes Primary: intraoperative pain score (Likert scale)
Notes Turkey
Single centre
Istanbul University
Funding: not stated
Paper in Turkish
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Ocal 2002 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method unclear
Allocation concealment (selection bias) Unclear risk Method unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible owing to the nature
of the interventions
Blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Unclear risk Comparable age but not cause of infertility
Ozturk 2006
Methods Randomisation: method unclear
Allocation concealment: sealed envelopes
Blinding of participants/investigators: no
Blinding of assessors: no
No. randomised: 100
No. analysed: 100
Intention-to-treat analysis: yes
Power and sample calculations not reported
Duration of study: not stated
Participants Women scheduled to undergo transvaginal oocyte retrieval
Mean age: 33 to 35 years
Cause of infertility: tuboperitoneal, male factor, anovulation, unexplained
Similar demographic and infertility characteristics at baseline
Interventions 1. Control: conscious sedation and analgesia (IV remifentanil 0.25 mg/kg) only (N
= 50)
2. Intervention: conscious sedation and analgesia (IV remifentanil 0.25 mg/kg) and
paracervical block (10 mL lidocaine 1%) (N = 50)
All women not premedicated
Outcomes 1. Primary: intraoperative pain score (simple numerical rating scale (0 - no pain; 10 -
intolerable pain))
2. Secondary: fertilisation rate, pregnancy rate, patient satisfaction, side effects
Other outcomes reported: remifentanil consumption, duration of anaesthesia, duration
of procedure, no. of oocytes retrieved, retrieval rate
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Ozturk 2006 (Continued)
Notes Turkey
Single centre
Gazi University, Ankara
Funding: not stated
Definition of pregnancy not documented
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method unclear
Allocation concealment (selection bias) Low risk Closed envelope
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible owing to the nature
of the interventions
Blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
Ramsewak 1990
Methods Randomisation: by pharmacy
Allocation concealment: sealed envelopes kept in medicine cupboard
Blinding of participants/investigators: yes
Blinding of assessors: no
No. randomised: 30
No. analysed: 24
Intention-to-treat analysis: no
Power and sample calculations not reported
Duration of trial: 1 month, July 1989
Participants Women undergoing follicular aspiration
Mean age: not reported
Cause of infertility: not reported
Baseline characteristics comparison not reported
Interventions 1. Control: conscious sedation and analgesia (placebo of IV normal saline) (N = 12)
2. Intervention: conscious sedation and analgesia (IV fentanyl 100 µg) (N = 12)
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Ramsewak 1990 (Continued)
Outcomes Primary: intraoperative pain (VAS)
Notes England
Single centre
Sheffield Univerity
Funding: not stated
6 women (20%) excluded after randomisation
2 - transvaginal aspiration inaccessible
2 - spontaneous rupture of follicle before needle insertion
1 - failure to complete VAS score sheet
1 - ampoule accidentally broken
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation by pharmacy
Allocation concealment (selection bias) Low risk Adequate: sealed envelope
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Neithermedical and nursing personnel nor
the patient knew which ampoule was used
Blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk 6 women (20%) lost to follow-up, reasons
given
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Unclear risk Baseline demographic and infertility char-
acteristics comparison not reported
Sator-Katzenschlager 2006
Methods Randomisation: computer-generated
Allocation concealment: method unclear
Blinding of participants/investigators: yes
Blinding of assessors: yes
No. randomised: 94
No. analysed: 93
Intention-to-treat analysis: no
Power and sample calculations described
Duration of trial: 7 months, from April to December 2004
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Sator-Katzenschlager 2006 (Continued)
Participants Women undergoing oocyte aspiration
Mean age: 33 to 34 years
Cause of infertility: male factor, tubal disease, endometriosis, PCOS, unexplained
Similar demographic and infertility characteristics at baseline
Interventions Randomised in proportions of 1:1:1 to control and 2 interventions
1. Control: conscious sedation and analgesia (IV remifentanil 20 µg via PCS)
without needles and electrical stimulation (N = 30)
2. Intervention I: conscious sedation and analgesia (IV remifentanil 20 µg via PCS)
with auricular electro-acupuncture (N = 32)
3. Intervention II: conscious sedation and analgesia (IV remifentanil 20 µg via PCS)
with auricular acupuncture without electrical stimulation (N = 32)
All participants received IV metamizole 1 g 15 minutes before procedure
Outcomes Primary: intraoperative and postoperative pain scores (VAS 0 to 100)
Secondary: pregnancy rate, side effects, patient satisfaction (good, moderate, reject)
Notes Austria
Single centre
Medical University of Vienna
Funding: not stated
Definition of pregnancy not documented
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated
Allocation concealment (selection bias) Unclear risk Methods unclear
Blinding (performance bias and detection
bias)
All outcomes
Low risk Participants and investigators blinded to
the randomisation
A second gynaecologist performed oocyte
retrieval, and another doctor asked for out-
come parameters to ensure blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk One participant in control group excluded
owing to impaired compliance
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
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Stener-Victorin 1999
Methods Randomisation: random number table
Allocation concealment: sealed envelopes
Blinding of participants/investigators: no
Blinding of assessors: no
No. randomised: 150
No. analysed: 149
Intention-to-treat analysis: no
Power and sample calculations not reported
Duration of trial: 8 months, from September 1996 to May 1997
Participants Women undergoing oocyte aspiration
Mean age: 33 to 34 years (range 35 to 46 years)
Cause of infertility: male factor, tubal disease, endometriosis, unexplained
Similar demographic and infertility characteristics at baseline
Interventions 1. Control: conscious sedation and analgesia (IV alfentanil 0.25 to 0.5 mg and
atropine 0.25 mg) plus PCB (10 mL lidocaine (5 to 10 mg/mL)) (N = 75)
2. Intervention: electro-acupuncture plus PCB (10 mL lidocaine (5 to 10 mg/mL))
(N = 74)
No premedication in either group
Outcomes 1. Primary: intraoperative and postoperative pain (VAS 0 to 100)
2. Secondary: live birth rate, pregnancy rate, side effects
Notes Sweden
Multi-centre (3 IVF centres)
Goteburg University
Funding: Foundation for Acupuncture and Alternative Biological Treatment Methods,
and the Swedish Research Council
PCB (10 mL lidocaine): given at 5 mg/mL at one IVF centre and at 10 mg/mL at the
other 2 IVF centres
One participant in the control group (0.7%) was excluded after randomisation because
of protocol violation (received premedication)
Definition of pregnancy not documented
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Each centre used its own randomisation.
Method: random numbers table
Allocation concealment (selection bias) Low risk Adequate: sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible owing to the nature
of the interventions
Blinding of assessors not reported
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Stener-Victorin 1999 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk One participant lost to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
Stener-Victorin 2003
Methods Randomisation: in blocks of 20 to each group, random numbers table
Allocation concealment: sealed unlabelled envelopes
Blinding of participants/investigators: no
Blinding of assessors: no
No. randomised: 286
No. analysed: 274
Intention-to-treat analysis: no
Power and sample calculations described
Duration of trial: from 1999 to 2001
Participants Women undergoing oocyte aspiration
Mean age: 33 years (range 22 to 38 years)
Cause of infertility: male factor, tubal disease, endometriosis, PCOS, unexplained
Similar demographic and infertility characteristics at baseline
Interventions 1. Control: conscious sedation and analgesia (IV alfentanil, dosage not stated) plus
PCB (lidocaine, dosage not stated) (N = 145)
2. Intervention: electro-acupuncture (EA) plus PCB (lidocaine, dosage not stated)
(N = 141)
No premedication in either group
Outcomes 1. Primary: primary: intraoperative and postoperative pain (VAS 0 to 100)
2. Secondary: ongoing pregnancy rate, pregnancy rate
Notes Sweden
Multi-centre (5 IVF centres)
Goteburg University
Funding: Hjalmar Svensson’s Foundation, the Wilhelm and Martina Lundgren’s Foun-
dation
Twelve women (4%) dropped out (7 in control group, 5 in intervention group):
4 - administration failure
1 - fall in blood pressure
1 - nausea
6 - withdrew voluntarily
Definition of pregnancy not documented
Risk of bias
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Stener-Victorin 2003 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Each centre used its own randomisation
Method: random numbers table
Allocation concealment (selection bias) Low risk Adequate: sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible owing to the nature
of the interventions
Blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 12 participants lost to follow-up (4%)
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
Thompson 2000
Methods Randomisation: computer-generated
Allocation concealment: sealed opaque envelopes
Blinding of participants/investigators: no
Blinding of assessors: no
No. randomised: 112
No. analysed: 112
Intention-to-treat analysis: yes
Power and sample calculations described
Duration of trial: not stated
Participants Women undergoing outpatient oocyte recovery
Mean age: 32 to 34 years
Cause of infertility: not reported
Similar baseline characteristics of age, height and weight, and history of previous oocyte
recovery
Interventions 1. Control: patient-controlled sedation and analgesia (inhalational isodesox via
mask) (N = 57)
2. Intervention: physician-controlled sedation and analgesia (IV fentanyl 25 µg and
midazolam 2 mg) (N = 55)
Outcomes 1. Primary: mean (unclear whether intraoperative or postoperative) pain score (VAS
0 to 100)
2. Secondary: clinical pregnancy rate, side effects, patient satisfaction (Likert scale),
adverse effects
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Thompson 2000 (Continued)
Notes Scotland
Single centre
Aberdeen University
Funding: not stated
Definition of pregnancy not documented
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated
Allocation concealment (selection bias) Low risk Adequate: sealed envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible owing to the nature
of the interventions
Blinding of assessors not reported
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Low risk Comparable demographic and infertility
characteristics at baseline
Zelcer 1992
Methods Randomisation: method unclear
Allocation concealment: method unclear
Blinding of participants/investigators: no
Blinding of assessors: yes
No. randomised: 80
No. analysed: 80
Intention-to-treat analysis: yes
Power and sample calculations not reported
Duration of trial: not stated
Participants Women presenting for outpatient oocyte retrieval
Mean age: 32 to 34 years
Cause of infertility: not reported
Similar baseline characteristics of age, height, and weight
Interventions 1. Control: patient-controlled sedation/analgesia (IV alfentanil 5 to 10 µg/kg) via a
delivery system (N = 40)
2. Intervention: physician-administered sedation/analgesia (IV alfentanil 5 to 10 µg/
kg) (N = 40)
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Zelcer 1992 (Continued)
All participants premedicated with midazolam 0.02 mg/kg
Outcomes 1. Primary: intraoperative pain (VAS)
2. Secondary: side effects
Notes USA
Single centre
University of Texas
Funding: Janssen-Cilag
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method unclear
Allocation concealment (selection bias) Unclear risk Method unclear
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk Blinding not possible owing to the nature
of the interventions
Postoperative side effects recorded by staff
unaware of treatment groups
Incomplete outcome data (attrition bias)
All outcomes
Low risk No apparent loss to follow-up
Selective reporting (reporting bias) Low risk All prespecified outcomes reported
Other bias Unclear risk Comparable baseline characteristics of age,
height, and weight but not cause of infer-
tility
Types of analgesic
Diazepam - sedative and anxiolytic
Diclofenac suppository - analgesic
Dolantin - analgesic, same as pethidine
Electro-acupuncture - pain-relieving method that activates endogenous pain-inhibiting systems such as the spinal/segmental gate
mechanism and the endogenous opoid systems. Any acupuncture effect rests on physiological and/or psychological mechanisms
Fentanyl/alfentanil/remifentanil - analgesia
Isodesox -analgesic and sedative inhalational agent
Midazolam - sedative and anxiolytic
Pethidine - analgesic
Pirosikam - analgesic (non-steroidal anti-inflammatory drug - NSAID)
Propofol - sedative and anxiolytic
Abbreviations
ASA = American Society of Anesthesiologists
BMI = body mass index
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EA = electro-acupuncture
IM = intramuscular
IV = intravenous
IVF = in vitro fertilisation
µg = microgram
mg = milligram
mg/kg = milligrams per kilogram
min = minute
mL = millilitre
no. = number
PCB = paracervical block. This involves injecting local anaesthetic adjacent to the cervix. Epidural analgesia involves injecting local
anaesthetic into the epidural space close to the spinal cord to numb the lower part of the body
PCS = patient-controlled sedation and analgesia
PAS = physician-administered sedation and analgesia
PCOS = polycystic ovary syndrome
TCI = system that maintains a particular target plasma drug concentration via standard pharmacokinetic equations
VAS = visual analogue scale, usually a 100-mm linear analogue scale
yr = year
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Atashkhoii 2006 Unable to obtain evidence of randomisation
Bovenschen 2002 Conscious sedation and analgesia not one of the comparators
Bumen 2010 Conscious sedation and analgesia not one of the comparators
Casati 1999 Conscious sedation and analgesia not one of the comparators
Corson 1994 Conscious sedation and analgesia not one of the comparators
Godoy 1993 Conscious sedation and analgesia not one of the comparators
Gotz 2014 Unable to obtain evidence of randomisation
Hadimioglu 2002 General anaesthesia. Conscious sedation not one of the comparators
Hong 2005 Conscious sedation and analgesia among low- and high-anxiety patients. No comparison with another technique
Manica 1993 Spinal anaesthesia dose finding. Conscious sedation and analgesia not one of the comparators
Martin 1999 Spinal anaesthesia. Conscious sedation and analgesia not one of the comparators
Muir 1995 Subperitoneal xylocaine. Spinal anaesthesia dose finding. Conscious sedation and analgesia not one of the
comparators
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(Continued)
Ng 1999 Paracervical block with lignocaine vs normal saline vs no paracervical block. Conscious sedation and analgesia
not one of the comparators
Ng 2000 Paracervical block dose finding. Conscious sedation and analgesia not one of the comparators
Ng 2002 Premedication versus no premedication. Conscious sedation and analgesia not one of the comparators
Ng 2003 Paracervical block dose finding. Conscious sedation and analgesia not one of the comparators
Oliveira 2016 Conscious sedation and analgesia not one of the comparators
Ongun 2002 Conscious sedation and analgesia not one of the comparators
Ramzy 2001 Conscious sedation and analgesia not one of the comparators
Saleh 2012 Conscious sedation and analgesia not one of the comparators
Sarikaya 2011 Population not clarified. No response from trial author when contacted
Singh 2014 Unable to obtain evidence of randomisation
Tsen 2001 Spinal anaesthesia. Conscious sedation not one of the comparators
Zaccabri 2001 Paracervical block vs vaginal anaesthetic cream. Conscious sedation and analgesia not one of the comparators
Zhang 2013 Conscious sedation and analgesia not one of the comparators
Characteristics of studies awaiting assessment [ordered by study ID]
Chen 2012
Methods Randomisation: random numbers table used to divide into 2 groups
Allocation concealment: not reported
Blinding of participants/investigators: not reported
Blinding of assessors: not reported
No. randomised: 134
No. analysed: 134
Intention-to-treat analysis: yes
Power and sample calculations: not described
Duration of trial: not stated
Participants Patients undergoing IVF-E
Interventions 1. Control: intramuscular (IM) Dolantin 50 milligrams (mg) 30 minutes before oocyte retrieval (N = 67)
2. Intervention: IM Dolantin 50 mg 30 minutes before electro-acupuncture (N = 67)
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Chen 2012 (Continued)
Outcomes 1. Primary: intraoperative pain (World Health Organization pain scale: Grade I (scores 1 to 3, minimal pain), Grade
II (scores 4 to 6, mild pain), Grade III (scores 7 to 9, moderate pain), Grade IV (scores 10 to 12, severe pain)):
postoperative (1 hour (h), 2 hours postoperatively) abdominal pain
2. Secondary: side effects of analgesia
Notes China
Reproductive Medicine Centre
Funding: Gansu Province
Paper in Chinese
NB. Data unclear, awaiting response from trial authors
IM = intramuscular
Characteristics of ongoing studies [ordered by study ID]
Kassira 2015
Trial name or title A randomised controlled trial of oral acetaminophen for analgesic control after transvaginal oocyte retrieval
Methods Double-blind randomised controlled trial
Participants Women undergoing IVF
Interventions Transvaginal oocyte retrieval
Outcomes Post-procedure pain
Starting date Not clear
Contact information Email of co-author: mpowell77@sky.com
Notes Conference abstract published 2015. Trial authors/co-authors contacted, no response
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D A T A A N D A N A L Y S E S
Comparison 1. Conscious sedation + analgesia (CSA) versus placebo
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain during needle insertion
(VAS 0 to 10)
1 24 Mean Difference (IV, Fixed, 95% CI) -1.70 [-2.38, -1.02]
2 Pain during follicle aspiration
(VAS 0 to 10)
1 24 Mean Difference (IV, Fixed, 95% CI) -1.30 [-1.88, -0.72]
Comparison 2. Conscious sedation + analgesia (CSA) versus other active interventions
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Intraoperative pain 2 Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 CSA vs CSA +
acupuncture (VAS 0 to 10)
1 62 Mean Difference (IV, Random, 95% CI) 1.0 [0.18, 1.82]
1.2 CSA vs CSA + electro-
acupuncture (VAS 0 to 10)
1 62 Mean Difference (IV, Random, 95% CI) 3.00 [2.23, 3.77]
1.3 CSA vs CSA + electro-
acupuncture (Pain scale 1 to
12)
1 316 Mean Difference (IV, Random, 95% CI) 1.70 [1.07, 2.33]
2 Postoperative pain 2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 CSA vs CSA +
acupuncture (VAS 0 to 10)
1 61 Mean Difference (IV, Fixed, 95% CI) 0.60 [-0.10, 1.30]
2.2 CSA vs CSA + electro-
acupuncture (VAS 0 to 10)
1 61 Mean Difference (IV, Fixed, 95% CI) 2.1 [1.40, 2.80]
2.3 CSA vs general anaesthesia
(Likert 0 to 3)
1 50 Mean Difference (IV, Fixed, 95% CI) -1.90 [-2.24, -1.56]
3 Pregnancy 3 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 CSA vs CSA +
acupuncture
1 61 Odds Ratio (M-H, Fixed, 95% CI) 0.61 [0.20, 1.86]
3.2 CSA vs CSA + electro-
acupuncture
1 61 Odds Ratio (M-H, Fixed, 95% CI) 0.22 [0.07, 0.66]
3.3 CSA vs general anaesthesia 2 108 Odds Ratio (M-H, Fixed, 95% CI) 1.0 [0.43, 2.35]
4 Postop vomiting and/or
vomiting
2 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
4.1 CSA vs CSA +
acupuncture
1 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 CSA vs general anaesthesia 1 Odds Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Satisfaction 2 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 CSA vs general anaesthesia 2 108 Odds Ratio (M-H, Fixed, 95% CI) 0.66 [0.11, 4.04]
6 Postoperative complications
(airway obstruction)
1 58 Odds Ratio (M-H, Fixed, 95% CI) 0.14 [0.02, 1.22]
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6.1 CSA vs general anaesthesia 1 58 Odds Ratio (M-H, Fixed, 95% CI) 0.14 [0.02, 1.22]
7 Postoperative complications
(mask ventilation)
1 58 Odds Ratio (M-H, Fixed, 95% CI) 0.05 [0.01, 0.20]
7.1 CSA vs general anaesthesia 1 58 Odds Ratio (M-H, Fixed, 95% CI) 0.05 [0.01, 0.20]
Comparison 3. Conscious sedation + analgesia (CSA) + paracervical block versus other interventions
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Intraoperative pain (VAS 0 to
10)
4 Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.1 CSA + paracervical block
versus electro-acupuncture +
paracervical block
4 781 Mean Difference (IV, Fixed, 95% CI) -0.66 [-0.93, -0.39]
2 Postoperative pain 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 CSA + paracervical block
vs general anaesthesia
1 50 Mean Difference (IV, Fixed, 95% CI) 0.49 [-0.13, 1.11]
2.2 CSA + paracervical block
vs spinal anaesthesia
1 36 Mean Difference (IV, Fixed, 95% CI) 1.02 [0.48, 1.56]
3 Live birth or ongoing pregnancy 2 393 Odds Ratio (M-H, Fixed, 95% CI) 1.20 [0.78, 1.86]
3.1 CSA + paracervical block
vs electro-acupuncture +
paracervical block
1 149 Odds Ratio (M-H, Fixed, 95% CI) 2.35 [1.09, 5.05]
3.2 CSA + paracervical block
vs electro-acupuncture +
paracervical block
1 244 Odds Ratio (M-H, Fixed, 95% CI) 0.86 [0.50, 1.47]
4 Pregnancy 7 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 CSA + paracervical block
vs general anaesthesia
1 51 Odds Ratio (M-H, Fixed, 95% CI) 0.70 [0.22, 2.26]
4.2 CSA + paracervical block
vs spinal anaesthesia
1 38 Odds Ratio (M-H, Fixed, 95% CI) 0.93 [0.24, 3.65]
4.3 CSA + paracervical block
vs paracervical block only
1 150 Odds Ratio (M-H, Fixed, 95% CI) 0.93 [0.44, 1.96]
4.4 CSA + paracervical block
vs electro-acupuncture +
paracervical block
4 783 Odds Ratio (M-H, Fixed, 95% CI) 0.96 [0.72, 1.29]
4.5 CSA + paracervical block
vs CSA alone
1 100 Odds Ratio (M-H, Fixed, 95% CI) 0.62 [0.28, 1.36]
5 Fertilisation rate per woman 1 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 CSA + paracervical block
vs paracervical block only
1 150 Odds Ratio (M-H, Fixed, 95% CI) 0.83 [0.42, 1.66]
6 Postoperative nausea and/or
vomiting
2 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 CSA + paracervical block
vs CS only
2 140 Odds Ratio (M-H, Fixed, 95% CI) 0.42 [0.18, 0.97]
7 Patient satisfaction by Likert
scale: report of ’excellent and
satisfactory’
1 150 Odds Ratio (M-H, Fixed, 95% CI) 1.63 [0.68, 3.89]
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7.1 CSA + paracervical block
vs paracervical block only
1 150 Odds Ratio (M-H, Fixed, 95% CI) 1.63 [0.68, 3.89]
Comparison 4. Patient-controlled versus physician-controlled sedation + analgesia (CSA)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Intraoperative pain score (VAS 0
to 10)
4 Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.1 Pt-controlled vs physician-
controlled CSA
4 379 Mean Difference (IV, Fixed, 95% CI) 0.60 [0.16, 1.03]
2 Intraoperative pain score
excluding inhalational
sedation/analgesia (VAS 0 to
10)
3 267 Mean Difference (IV, Fixed, 95% CI) 0.47 [-0.01, 0.95]
2.1 Pt-controlled vs physician-
controlled CSA
3 267 Mean Difference (IV, Fixed, 95% CI) 0.47 [-0.01, 0.95]
3 Postoperative pain score (VAS 0
to 10)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1 Pt-controlled vs physician-
controlled CSA
1 106 Mean Difference (IV, Fixed, 95% CI) 1.2 [0.26, 2.14]
4 Pregnancy rate per woman 3 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 Pt-controlled vs physician-
controlled CSA
3 294 Odds Ratio (M-H, Fixed, 95% CI) 0.90 [0.51, 1.60]
5 Fertilisation rate per woman 1 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Pt-controlled vs physician-
controlled CSA
1 106 Odds Ratio (M-H, Fixed, 95% CI) 1.17 [0.54, 2.50]
6 Postoperative nausea: no. of
patients
1 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 Pt-controlled vs physician-
controlled CSA
1 80 Odds Ratio (M-H, Fixed, 95% CI) 1.0 [0.19, 5.28]
7 Patient satisfaction by LIkert
scale: report of ’very and
moderately satisfied’
1 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
7.1 Pt-controlled vs physician-
controlled CSA
1 81 Odds Ratio (M-H, Fixed, 95% CI) 1.95 [0.34, 11.28]
8 Patient satisfaction (VAS 0 to
10)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
8.1 Pt-controlled vs physician-
controlled CSA
1 106 Mean Difference (IV, Fixed, 95% CI) 0.20 [-0.64, 1.04]
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Comparison 5. Conscious sedation (CSA) + analgesia via different agents or dosages
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Intraoperative pain score at 5
minutes (VAS 0 to 10)
1 52 Mean Difference (IV, Fixed, 95% CI) -0.74 [-1.48, 0.00]
2 Intraoperative pain score at 10
minutes (VAS 0 to 10)
1 52 Mean Difference (IV, Fixed, 95% CI) -0.90 [-1.64, -0.16]
3 Postoperative pain score at 20
minutes (VAS 0 to 10)
1 52 Mean Difference (IV, Fixed, 95% CI) 0.42 [-0.04, 0.88]
4 Patient satisfaction rate 2 Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 CSA with propofol vs
CSA with midazolam
1 47 Odds Ratio (M-H, Fixed, 95% CI) 0.42 [0.04, 4.94]
4.2 CSA with
dexmedetomidine vs CSA with
midazolam (very satisfied)
1 52 Odds Ratio (M-H, Fixed, 95% CI) 3.07 [0.98, 9.59]
Analysis 1.1. Comparison 1 Conscious sedation + analgesia (CSA) versus placebo, Outcome 1 Pain during
needle insertion (VAS 0 to 10).
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 1 Conscious sedation + analgesia (CSA) versus placebo
Outcome: 1 Pain during needle insertion (VAS 0 to 10)
Study or subgroup iv fentanyl Placebo
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Ramsewak 1990 12 3.9 (0.8) 12 5.6 (0.9) 100.0 % -1.70 [ -2.38, -1.02 ]
Total (95% CI) 12 12 100.0 % -1.70 [ -2.38, -1.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.89 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.2. Comparison 1 Conscious sedation + analgesia (CSA) versus placebo, Outcome 2 Pain during
follicle aspiration (VAS 0 to 10).
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 1 Conscious sedation + analgesia (CSA) versus placebo
Outcome: 2 Pain during follicle aspiration (VAS 0 to 10)
Study or subgroup iv fentanyl Placebo
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Ramsewak 1990 12 2.5 (0.5) 12 3.8 (0.9) 100.0 % -1.30 [ -1.88, -0.72 ]
Total (95% CI) 12 12 100.0 % -1.30 [ -1.88, -0.72 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.37 (P = 0.000012)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Favours iv fentanyl Favours placebo
81Pain relief for women undergoing oocyte retrieval for assisted reproduction (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.1. Comparison 2 Conscious sedation + analgesia (CSA) versus other active interventions,
Outcome 1 Intraoperative pain.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 2 Conscious sedation + analgesia (CSA) versus other active interventions
Outcome: 1 Intraoperative pain
Study or subgroup Conscious sedation Other
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 CSA vs CSA + acupuncture (VAS 0 to 10)
Sator-Katzenschlager 2006 30 5.9 (1.6) 32 4.9 (1.7) 100.0 % 1.00 [ 0.18, 1.82 ]
Subtotal (95% CI) 30 32 100.0 % 1.00 [ 0.18, 1.82 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.39 (P = 0.017)
2 CSA vs CSA + electro-acupuncture (VAS 0 to 10)
Sator-Katzenschlager 2006 30 5.9 (1.6) 32 2.9 (1.5) 100.0 % 3.00 [ 2.23, 3.77 ]
Subtotal (95% CI) 30 32 100.0 % 3.00 [ 2.23, 3.77 ]
Heterogeneity: not applicable
Test for overall effect: Z = 7.60 (P < 0.00001)
3 CSA vs CSA + electro-acupuncture (Pain scale 1 to 12)
Meng 2008 170 5.1 (3) 146 3.4 (2.7) 100.0 % 1.70 [ 1.07, 2.33 ]
Subtotal (95% CI) 170 146 100.0 % 1.70 [ 1.07, 2.33 ]
Heterogeneity: not applicable
Test for overall effect: Z = 5.30 (P < 0.00001)
Test for subgroup differences: Chi2 = 12.77, df = 2 (P = 0.00), I2 =84%
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Analysis 2.2. Comparison 2 Conscious sedation + analgesia (CSA) versus other active interventions,
Outcome 2 Postoperative pain.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 2 Conscious sedation + analgesia (CSA) versus other active interventions
Outcome: 2 Postoperative pain
Study or subgroup Conscious sedation Other
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 CSA vs CSA + acupuncture (VAS 0 to 10)
Sator-Katzenschlager 2006 29 3.2 (1.4) 32 2.6 (1.4) 100.0 % 0.60 [ -0.10, 1.30 ]
Subtotal (95% CI) 29 32 100.0 % 0.60 [ -0.10, 1.30 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.67 (P = 0.095)
2 CSA vs CSA + electro-acupuncture (VAS 0 to 10)
Sator-Katzenschlager 2006 29 3.2 (1.4) 32 1.1 (1.4) 100.0 % 2.10 [ 1.40, 2.80 ]
Subtotal (95% CI) 29 32 100.0 % 2.10 [ 1.40, 2.80 ]
Heterogeneity: not applicable
Test for overall effect: Z = 5.85 (P < 0.00001)
3 CSA vs general anaesthesia (Likert 0 to 3)
Ben-Shlomo 1999 25 0.2 (0.5) 25 2.1 (0.7) 100.0 % -1.90 [ -2.24, -1.56 ]
Subtotal (95% CI) 25 25 100.0 % -1.90 [ -2.24, -1.56 ]
Heterogeneity: not applicable
Test for overall effect: Z = 11.04 (P < 0.00001)
Test for subgroup differences: Chi2 = 121.08, df = 2 (P = 0.00), I2 =98%
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Analysis 2.3. Comparison 2 Conscious sedation + analgesia (CSA) versus other active interventions,
Outcome 3 Pregnancy.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 2 Conscious sedation + analgesia (CSA) versus other active interventions
Outcome: 3 Pregnancy
Study or subgroup Conscious sedation Other Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 CSA vs CSA + acupuncture
Sator-Katzenschlager 2006 7/29 11/32 100.0 % 0.61 [ 0.20, 1.86 ]
Subtotal (95% CI) 29 32 100.0 % 0.61 [ 0.20, 1.86 ]
Total events: 7 (Conscious sedation), 11 (Other)
Heterogeneity: not applicable
Test for overall effect: Z = 0.87 (P = 0.38)
2 CSA vs CSA + electro-acupuncture
Sator-Katzenschlager 2006 (1) 7/29 19/32 100.0 % 0.22 [ 0.07, 0.66 ]
Subtotal (95% CI) 29 32 100.0 % 0.22 [ 0.07, 0.66 ]
Total events: 7 (Conscious sedation), 19 (Other)
Heterogeneity: not applicable
Test for overall effect: Z = 2.70 (P = 0.0068)
3 CSA vs general anaesthesia
Ben-Shlomo 1999 5/25 5/25 37.9 % 1.00 [ 0.25, 4.00 ]
Matsota 2012 10/29 10/29 62.1 % 1.00 [ 0.34, 2.95 ]
Subtotal (95% CI) 54 54 100.0 % 1.00 [ 0.43, 2.35 ]
Total events: 15 (Conscious sedation), 15 (Other)
Heterogeneity: Chi2 = 0.0, df = 1 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Chi2 = 4.59, df = 2 (P = 0.10), I2 =56%
0.01 0.1 1 10 100
Favours control Fav’rs conscious sedation
(1) Analysis 2.3.1 refers to comparison between CS plus placebo acupuncture versus CS plus electroacupuncture. Analysis 2.3.2 refers to comparison between CS plus
placebo acupuncture and CS plus acupuncture.
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Analysis 2.4. Comparison 2 Conscious sedation + analgesia (CSA) versus other active interventions,
Outcome 4 Postop vomiting and/or vomiting.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 2 Conscious sedation + analgesia (CSA) versus other active interventions
Outcome: 4 Postop vomiting and/or vomiting
Study or subgroup Conscious sedation Other Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 CSA vs CSA + acupuncture
Sator-Katzenschlager 2006 (1) 7/30 5/32 1.64 [ 0.46, 5.88 ]
Sator-Katzenschlager 2006 (2) 7/30 7/32 1.09 [ 0.33, 3.58 ]
2 CSA vs general anaesthesia
Ben-Shlomo 1999 2/25 4/25 0.46 [ 0.08, 2.75 ]
0.01 0.1 1 10 100
Fav’rs conscious sedation Favours control
(1) CS + analgesia + placebo acupuncture versus CS + analgesia + acupuncture
(2) CS + analgesia + placebo acupuncture versus CS + analgesia + electroacupuncture
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Analysis 2.5. Comparison 2 Conscious sedation + analgesia (CSA) versus other active interventions,
Outcome 5 Satisfaction.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 2 Conscious sedation + analgesia (CSA) versus other active interventions
Outcome: 5 Satisfaction
Study or subgroup Conscious sedation Other Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 CSA vs general anaesthesia
Ben-Shlomo 1999 25/25 24/25 16.1 % 3.12 [ 0.12, 80.39 ]
Matsota 2012 27/29 29/29 83.9 % 0.19 [ 0.01, 4.06 ]
Subtotal (95% CI) 54 54 100.0 % 0.66 [ 0.11, 4.04 ]
Total events: 52 (Conscious sedation), 53 (Other)
Heterogeneity: Chi2 = 1.53, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 0.45 (P = 0.65)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours control Fav’rs conscious sedation
Analysis 2.6. Comparison 2 Conscious sedation + analgesia (CSA) versus other active interventions,
Outcome 6 Postoperative complications (airway obstruction).
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 2 Conscious sedation + analgesia (CSA) versus other active interventions
Outcome: 6 Postoperative complications (airway obstruction)
Study or subgroup conscious sedation general anaethesia Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 CSA vs general anaesthesia
Matsota 2012 1/29 6/29 100.0 % 0.14 [ 0.02, 1.22 ]
Total (95% CI) 29 29 100.0 % 0.14 [ 0.02, 1.22 ]
Total events: 1 (conscious sedation), 6 (general anaethesia)
Heterogeneity: not applicable
Test for overall effect: Z = 1.78 (P = 0.075)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 2.7. Comparison 2 Conscious sedation + analgesia (CSA) versus other active interventions,
Outcome 7 Postoperative complications (mask ventilation).
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 2 Conscious sedation + analgesia (CSA) versus other active interventions
Outcome: 7 Postoperative complications (mask ventilation)
Study or subgroup conscious dedation general anaethesia Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 CSA vs general anaesthesia
Matsota 2012 5/29 23/29 100.0 % 0.05 [ 0.01, 0.20 ]
Total (95% CI) 29 29 100.0 % 0.05 [ 0.01, 0.20 ]
Total events: 5 (conscious dedation), 23 (general anaethesia)
Heterogeneity: not applicable
Test for overall effect: Z = 4.33 (P = 0.000015)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours CS Favours control
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Analysis 3.1. Comparison 3 Conscious sedation + analgesia (CSA) + paracervical block versus other
interventions, Outcome 1 Intraoperative pain (VAS 0 to 10).
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 3 Conscious sedation + analgesia (CSA) + paracervical block versus other interventions
Outcome: 1 Intraoperative pain (VAS 0 to 10)
Study or subgroup
CS +
paracervical
block Other
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 CSA + paracervical block versus electro-acupuncture + paracervical block
Gejervall 2005 80 2.98 (2.34) 78 4.85 (2.68) 11.9 % -1.87 [ -2.66, -1.08 ]
Humaidan 2004 100 1.8 (1.7) 100 2.6 (1.8) 31.2 % -0.80 [ -1.29, -0.31 ]
Stener-Victorin 1999 74 2.66 (2.2) 75 3.01 (1.94) 16.5 % -0.35 [ -1.02, 0.32 ]
Stener-Victorin 2003 138 2.64 (1.83) 136 2.96 (1.77) 40.4 % -0.32 [ -0.75, 0.11 ]
Subtotal (95% CI) 392 389 100.0 % -0.66 [ -0.93, -0.39 ]
Heterogeneity: Chi2 = 12.72, df = 3 (P = 0.01); I2 =76%
Test for overall effect: Z = 4.77 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Conscious sedation + analgesia (CSA) + paracervical block versus other
interventions, Outcome 2 Postoperative pain.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 3 Conscious sedation + analgesia (CSA) + paracervical block versus other interventions
Outcome: 2 Postoperative pain
Study or subgroup
CS +
paracervical
block General anaesthetic
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 CSA + paracervical block vs general anaesthesia
Guasch 2005 23 1.17 (1.1) 27 0.68 (1.13) 100.0 % 0.49 [ -0.13, 1.11 ]
Subtotal (95% CI) 23 27 100.0 % 0.49 [ -0.13, 1.11 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.55 (P = 0.12)
2 CSA + paracervical block vs spinal anaesthesia
Guasch 2005 23 1.17 (1.1) 13 0.15 (0.55) 100.0 % 1.02 [ 0.48, 1.56 ]
Subtotal (95% CI) 23 13 100.0 % 1.02 [ 0.48, 1.56 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.70 (P = 0.00021)
Test for subgroup differences: Chi2 = 1.60, df = 1 (P = 0.21), I2 =37%
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Analysis 3.3. Comparison 3 Conscious sedation + analgesia (CSA) + paracervical block versus other
interventions, Outcome 3 Live birth or ongoing pregnancy.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 3 Conscious sedation + analgesia (CSA) + paracervical block versus other interventions
Outcome: 3 Live birth or ongoing pregnancy
Study or subgroup
CS +
paracervical
block Other Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 CSA + paracervical block vs electro-acupuncture + paracervical block
Stener-Victorin 1999 25/75 13/74 23.2 % 2.35 [ 1.09, 5.05 ]
Subtotal (95% CI) 75 74 23.2 % 2.35 [ 1.09, 5.05 ]
Total events: 25 (CS + paracervical block), 13 (Other)
Heterogeneity: not applicable
Test for overall effect: Z = 2.18 (P = 0.029)
2 CSA + paracervical block vs electro-acupuncture + paracervical block
Stener-Victorin 2003 37/119 43/125 76.8 % 0.86 [ 0.50, 1.47 ]
Subtotal (95% CI) 119 125 76.8 % 0.86 [ 0.50, 1.47 ]
Total events: 37 (CS + paracervical block), 43 (Other)
Heterogeneity: not applicable
Test for overall effect: Z = 0.55 (P = 0.58)
Total (95% CI) 194 199 100.0 % 1.20 [ 0.78, 1.86 ]
Total events: 62 (CS + paracervical block), 56 (Other)
Heterogeneity: Chi2 = 4.41, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 0.85 (P = 0.40)
Test for subgroup differences: Chi2 = 4.41, df = 1 (P = 0.04), I2 =77%
0.01 0.1 1 10 100
Favours control Favours CS + block
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Analysis 3.4. Comparison 3 Conscious sedation + analgesia (CSA) + paracervical block versus other
interventions, Outcome 4 Pregnancy.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 3 Conscious sedation + analgesia (CSA) + paracervical block versus other interventions
Outcome: 4 Pregnancy
Study or subgroup
CS +
paracervical
block Other Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 CSA + paracervical block vs general anaesthesia
Guasch 2005 8/27 9/24 100.0 % 0.70 [ 0.22, 2.26 ]
Subtotal (95% CI) 27 24 100.0 % 0.70 [ 0.22, 2.26 ]
Total events: 8 (CS + paracervical block), 9 (Other)
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.55)
2 CSA + paracervical block vs spinal anaesthesia
Guasch 2005 5/14 9/24 100.0 % 0.93 [ 0.24, 3.65 ]
Subtotal (95% CI) 14 24 100.0 % 0.93 [ 0.24, 3.65 ]
Total events: 5 (CS + paracervical block), 9 (Other)
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.91)
3 CSA + paracervical block vs paracervical block only
Ng 2001 18/75 19/75 100.0 % 0.93 [ 0.44, 1.96 ]
Subtotal (95% CI) 75 75 100.0 % 0.93 [ 0.44, 1.96 ]
Total events: 18 (CS + paracervical block), 19 (Other)
Heterogeneity: not applicable
Test for overall effect: Z = 0.19 (P = 0.85)
4 CSA + paracervical block vs electro-acupuncture + paracervical block
Gejervall 2005 23/80 26/80 20.4 % 0.84 [ 0.43, 1.64 ]
Humaidan 2004 46/100 50/100 29.7 % 0.85 [ 0.49, 1.48 ]
Stener-Victorin 1999 28/75 19/74 13.2 % 1.72 [ 0.86, 3.48 ]
Stener-Victorin 2003 43/136 49/138 36.6 % 0.84 [ 0.51, 1.39 ]
Subtotal (95% CI) 391 392 100.0 % 0.96 [ 0.72, 1.29 ]
Total events: 140 (CS + paracervical block), 144 (Other)
Heterogeneity: Chi2 = 3.29, df = 3 (P = 0.35); I2 =9%
Test for overall effect: Z = 0.27 (P = 0.78)
5 CSA + paracervical block vs CSA alone
Ozturk 2006 24/50 30/50 100.0 % 0.62 [ 0.28, 1.36 ]
Subtotal (95% CI) 50 50 100.0 % 0.62 [ 0.28, 1.36 ]
Total events: 24 (CS + paracervical block), 30 (Other)
0.01 0.1 1 10 100
Favours control Favours CS + block
(Continued . . . )
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(. . . Continued)
Study or subgroup
CS +
paracervical
block Other Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: not applicable
Test for overall effect: Z = 1.20 (P = 0.23)
Test for subgroup differences: Chi2 = 1.25, df = 4 (P = 0.87), I2 =0.0%
0.01 0.1 1 10 100
Favours control Favours CS + block
Analysis 3.5. Comparison 3 Conscious sedation + analgesia (CSA) + paracervical block versus other
interventions, Outcome 5 Fertilisation rate per woman.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 3 Conscious sedation + analgesia (CSA) + paracervical block versus other interventions
Outcome: 5 Fertilisation rate per woman
Study or subgroup
CS +
paracervical
block Other Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 CSA + paracervical block vs paracervical block only
Ng 2001 50/75 53/75 100.0 % 0.83 [ 0.42, 1.66 ]
Subtotal (95% CI) 75 75 100.0 % 0.83 [ 0.42, 1.66 ]
Total events: 50 (CS + paracervical block), 53 (Other)
Heterogeneity: not applicable
Test for overall effect: Z = 0.53 (P = 0.60)
0.01 0.1 1 10 100
Favours control Favours CS + block
92Pain relief for women undergoing oocyte retrieval for assisted reproduction (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.6. Comparison 3 Conscious sedation + analgesia (CSA) + paracervical block versus other
interventions, Outcome 6 Postoperative nausea and/or vomiting.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 3 Conscious sedation + analgesia (CSA) + paracervical block versus other interventions
Outcome: 6 Postoperative nausea and/or vomiting
Study or subgroup
CS +
paracervical
block Other Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 CSA + paracervical block vs CS only
Gunaydin 2007 1/20 0/20 2.7 % 3.15 [ 0.12, 82.16 ]
Ozturk 2006 10/50 21/50 97.3 % 0.35 [ 0.14, 0.84 ]
Subtotal (95% CI) 70 70 100.0 % 0.42 [ 0.18, 0.97 ]
Total events: 11 (CS + paracervical block), 21 (Other)
Heterogeneity: Chi2 = 1.66, df = 1 (P = 0.20); I2 =40%
Test for overall effect: Z = 2.04 (P = 0.042)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours CS + block Favours control
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Analysis 3.7. Comparison 3 Conscious sedation + analgesia (CSA) + paracervical block versus other
interventions, Outcome 7 Patient satisfaction by Likert scale: report of ’excellent and satisfactory’.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 3 Conscious sedation + analgesia (CSA) + paracervical block versus other interventions
Outcome: 7 Patient satisfaction by Likert scale: report of ’excellent and satisfactory’
Study or subgroup
CS +
paracervical
block Other Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 CSA + paracervical block vs paracervical block only
Ng 2001 65/75 60/75 100.0 % 1.63 [ 0.68, 3.89 ]
Total (95% CI) 75 75 100.0 % 1.63 [ 0.68, 3.89 ]
Total events: 65 (CS + paracervical block), 60 (Other)
Heterogeneity: not applicable
Test for overall effect: Z = 1.09 (P = 0.28)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 4.1. Comparison 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA),
Outcome 1 Intraoperative pain score (VAS 0 to 10).
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA)
Outcome: 1 Intraoperative pain score (VAS 0 to 10)
Study or subgroup patient sedation physician sedation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pt-controlled vs physician-controlled CSA
Bhattacharya 1997 39 3.85 (1.98) 42 4.61 (2.13) 23.6 % -0.76 [ -1.66, 0.14 ]
Lok 2002 51 5.3 (2.3) 55 3.5 (2.4) 23.7 % 1.80 [ 0.91, 2.69 ]
Thompson 2000 57 4.68 (3.47) 55 3.44 (2.13) 16.8 % 1.24 [ 0.18, 2.30 ]
Zelcer 1992 40 2.9 (1.8) 40 2.5 (1.5) 35.9 % 0.40 [ -0.33, 1.13 ]
Subtotal (95% CI) 187 192 100.0 % 0.60 [ 0.16, 1.03 ]
Heterogeneity: Chi2 = 17.46, df = 3 (P = 0.00057); I2 =83%
Test for overall effect: Z = 2.69 (P = 0.0071)
Test for subgroup differences: Not applicable
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Analysis 4.2. Comparison 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA),
Outcome 2 Intraoperative pain score excluding inhalational sedation/analgesia (VAS 0 to 10).
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA)
Outcome: 2 Intraoperative pain score excluding inhalational sedation/analgesia (VAS 0 to 10)
Study or subgroup patient sedation physician sedation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pt-controlled vs physician-controlled CSA
Bhattacharya 1997 39 3.85 (1.98) 42 4.61 (2.13) 28.4 % -0.76 [ -1.66, 0.14 ]
Lok 2002 51 5.3 (2.3) 55 3.5 (2.4) 28.4 % 1.80 [ 0.91, 2.69 ]
Zelcer 1992 40 2.9 (1.8) 40 2.5 (1.5) 43.2 % 0.40 [ -0.33, 1.13 ]
Total (95% CI) 130 137 100.0 % 0.47 [ -0.01, 0.95 ]
Heterogeneity: Chi2 = 15.78, df = 2 (P = 0.00038); I2 =87%
Test for overall effect: Z = 1.92 (P = 0.054)
Test for subgroup differences: Not applicable
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Analysis 4.3. Comparison 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA),
Outcome 3 Postoperative pain score (VAS 0 to 10).
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA)
Outcome: 3 Postoperative pain score (VAS 0 to 10)
Study or subgroup Patient sedation Physician sedation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pt-controlled vs physician-controlled CSA
Lok 2002 51 2.9 (2.7) 55 1.7 (2.2) 100.0 % 1.20 [ 0.26, 2.14 ]
Subtotal (95% CI) 51 55 100.0 % 1.20 [ 0.26, 2.14 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.50 (P = 0.013)
Test for subgroup differences: Not applicable
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Analysis 4.4. Comparison 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA),
Outcome 4 Pregnancy rate per woman.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA)
Outcome: 4 Pregnancy rate per woman
Study or subgroup Favours patient physician sedation Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Pt-controlled vs physician-controlled CSA
Lier 2014 10/36 12/40 33.3 % 0.90 [ 0.33, 2.43 ]
Lok 2002 8/51 13/55 42.8 % 0.60 [ 0.23, 1.60 ]
Thompson 2000 10/57 7/55 23.9 % 1.46 [ 0.51, 4.15 ]
Subtotal (95% CI) 144 150 100.0 % 0.90 [ 0.51, 1.60 ]
Total events: 28 (Favours patient), 32 (physician sedation)
Heterogeneity: Chi2 = 1.47, df = 2 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.34 (P = 0.73)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours patient Favours physician
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Analysis 4.5. Comparison 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA),
Outcome 5 Fertilisation rate per woman.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA)
Outcome: 5 Fertilisation rate per woman
Study or subgroup patient sedation physician sedation Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Pt-controlled vs physician-controlled CSA
Lok 2002 27/51 27/55 100.0 % 1.17 [ 0.54, 2.50 ]
Subtotal (95% CI) 51 55 100.0 % 1.17 [ 0.54, 2.50 ]
Total events: 27 (patient sedation), 27 (physician sedation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.40 (P = 0.69)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours patient Favours physician
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Analysis 4.6. Comparison 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA),
Outcome 6 Postoperative nausea: no. of patients.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA)
Outcome: 6 Postoperative nausea: no. of patients
Study or subgroup Patient sedation Physician sedation Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Pt-controlled vs physician-controlled CSA
Zelcer 1992 3/40 3/40 100.0 % 1.00 [ 0.19, 5.28 ]
Subtotal (95% CI) 40 40 100.0 % 1.00 [ 0.19, 5.28 ]
Total events: 3 (Patient sedation), 3 (Physician sedation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours patient Favours physician
Analysis 4.7. Comparison 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA),
Outcome 7 Patient satisfaction by LIkert scale: report of ’very and moderately satisfied’.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA)
Outcome: 7 Patient satisfaction by LIkert scale: report of ’very and moderately satisfied’
Study or subgroup patient sedation Physician sedation Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Pt-controlled vs physician-controlled CSA
Bhattacharya 1997 37/39 38/42 100.0 % 1.95 [ 0.34, 11.28 ]
Subtotal (95% CI) 39 42 100.0 % 1.95 [ 0.34, 11.28 ]
Total events: 37 (patient sedation), 38 (Physician sedation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.74 (P = 0.46)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours patient Favours physician
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Analysis 4.8. Comparison 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA),
Outcome 8 Patient satisfaction (VAS 0 to 10).
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 4 Patient-controlled versus physician-controlled sedation + analgesia (CSA)
Outcome: 8 Patient satisfaction (VAS 0 to 10)
Study or subgroup Patient sedation Physician sedation
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Pt-controlled vs physician-controlled CSA
Lok 2002 51 7.6 (2.3) 55 7.4 (2.1) 100.0 % 0.20 [ -0.64, 1.04 ]
Subtotal (95% CI) 51 55 100.0 % 0.20 [ -0.64, 1.04 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.47 (P = 0.64)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
Favours patient Favours physician
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Analysis 5.1. Comparison 5 Conscious sedation (CSA) + analgesia via different agents or dosages, Outcome
1 Intraoperative pain score at 5 minutes (VAS 0 to 10).
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 5 Conscious sedation (CSA) + analgesia via different agents or dosages
Outcome: 1 Intraoperative pain score at 5 minutes (VAS 0 to 10)
Study or subgroup dexmedetomidine midazolam
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Elnabtity 2017 26 4.03 (1.24) 26 4.77 (1.48) 100.0 % -0.74 [ -1.48, 0.00 ]
Total (95% CI) 26 26 100.0 % -0.74 [ -1.48, 0.00 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.95 (P = 0.051)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
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Analysis 5.2. Comparison 5 Conscious sedation (CSA) + analgesia via different agents or dosages, Outcome
2 Intraoperative pain score at 10 minutes (VAS 0 to 10).
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 5 Conscious sedation (CSA) + analgesia via different agents or dosages
Outcome: 2 Intraoperative pain score at 10 minutes (VAS 0 to 10)
Study or subgroup dexmedetomidine midazolam
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Elnabtity 2017 26 4 (1.29) 26 4.9 (1.42) 100.0 % -0.90 [ -1.64, -0.16 ]
Total (95% CI) 26 26 100.0 % -0.90 [ -1.64, -0.16 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.39 (P = 0.017)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
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Analysis 5.3. Comparison 5 Conscious sedation (CSA) + analgesia via different agents or dosages, Outcome
3 Postoperative pain score at 20 minutes (VAS 0 to 10).
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 5 Conscious sedation (CSA) + analgesia via different agents or dosages
Outcome: 3 Postoperative pain score at 20 minutes (VAS 0 to 10)
Study or subgroup dexmedetomidine midazolam
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Elnabtity 2017 26 3.78 (0.99) 26 3.36 (0.68) 100.0 % 0.42 [ -0.04, 0.88 ]
Total (95% CI) 26 26 100.0 % 0.42 [ -0.04, 0.88 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.78 (P = 0.075)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours dexmedetomidine Favours midazolam
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Analysis 5.4. Comparison 5 Conscious sedation (CSA) + analgesia via different agents or dosages, Outcome
4 Patient satisfaction rate.
Review: Pain relief for women undergoing oocyte retrieval for assisted reproduction
Comparison: 5 Conscious sedation (CSA) + analgesia via different agents or dosages
Outcome: 4 Patient satisfaction rate
Study or subgroup Midazolam Propofol Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 CSA with propofol vs CSA with midazolam
Cook 1993 20/22 24/25 100.0 % 0.42 [ 0.04, 4.94 ]
Subtotal (95% CI) 22 25 100.0 % 0.42 [ 0.04, 4.94 ]
Total events: 20 (Midazolam), 24 (Propofol)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
2 CSA with dexmedetomidine vs CSA with midazolam (very satisfied)
Elnabtity 2017 15/26 8/26 100.0 % 3.07 [ 0.98, 9.59 ]
Subtotal (95% CI) 26 26 100.0 % 3.07 [ 0.98, 9.59 ]
Total events: 15 (Midazolam), 8 (Propofol)
Heterogeneity: not applicable
Test for overall effect: Z = 1.93 (P = 0.054)
Test for subgroup differences: Chi2 = 2.07, df = 1 (P = 0.15), I2 =52%
0.01 0.1 1 10 100
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A P P E N D I C E S
Appendix 1. Cochrane Gynaecology and Fertility Group (CGFG) Specialised Register search
strategy
Searched from inception to 9 November 2017
Procite platform
Keywords CONTAINS “oocyte” or “oocyte aspiration” or “oocyte collection” or “oocyte donors” or “oocyte pick-up” or “oocyte pickup
techniques” or “oocyte retrieval” or “follicular aspiration” or “follicle aspiration” or “donor egg cycles” or “donor oocytes” or “Aspirating
ICSI” or “Aspiration” or Title CONTAINS “oocyte” or “oocyte aspiration” or “oocyte collection” or “oocyte donors” or “oocyte pick-
up” or “oocyte pickup techniques” or “oocyte retrieval” or “follicular aspiration” or “follicle aspiration” or “donor egg cycles” or “donor
oocytes” or “Aspirating ICSI” or “Aspiration”
AND
Keywords CONTAINS “conscious sedation” or “sedation” or “sedatives” or “sedatives, nonbarbituate” or “alprazolam” or “diazepam”
or “lorazepam” or “midazolam” or “midolazam” or “oxazepam” or “fentanyl” or “narcotics” or “opioid analgesia” or“ opioids” or
“bolus” or “antianxiety agents” or “anxiolytic” or “propofol” or “pain relief ” or “*Analgesics, Opioid” or “analgesics” or “analgesia” or
“anaesthetics” or “anaesthesia” or “acupuncture” or “electroacupuncture” or “pethidine” or Title CONTAINS “conscious sedation” or
“sedation” or “sedatives” or “sedatives, nonbarbituate” or “alprazolam” or “diazepam” or “lorazepam” or “midazolam” or “midolazam” or
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“oxazepam” or “fentanyl” or “fentenyl” or “narcotics” or “opioid analgesia” or “opioids” or “bolus” or “antianxiety agents” or “anxiolytic”
or “propofol” or “pain relief ” or “*Analgesics, Opioid” or “analgesics” or “analgesia” or “anaesthetics” or “anaesthesia” or “acupuncture”
or “electroacupuncture” or “pethidine”
(127 hits)
Appendix 2. Cochrane Register of Studies Online (CRSO) search strategy
Searched 9 November 2017
Web platform
#1 MESH DESCRIPTOR Fertilization in Vitro EXPLODE ALL TREES 1872
#2 MESH DESCRIPTOR Ovarian Follicle EXPLODE ALL TREES 517
#3 MESH DESCRIPTOR Oocytes EXPLODE ALL TREES 444
#4 MESH DESCRIPTOR Oocyte Retrieval EXPLODE ALL TREES 151
#5 MESH DESCRIPTOR Oocyte Donation EXPLODE ALL TREES 65
#6 MESH DESCRIPTOR Sperm Injections, Intracytoplasmic EXPLODE ALL TREES 487
#7 (oocyt* adj5 retriev*):TI,AB,KY 1229
#8 (oocyt* adj5 pickup*):TI,AB,KY 16
#9 (oocyt* adj5 pick up*):TI,AB,KY 54
#10 (egg* adj5 (retriev* or pick?up*)):TI,AB,KY 42
#11 (IVF or ICSI):TI,AB,KY 4062
#12 (vitro fertili*):TI,AB,KY 2170
#13 (intracytoplas* adj3 sperm*):TI,AB,KY 1354
#14 (egg* adj2 recover*):TI,AB,KY 8
#15 (oocyte* adj2 recover*):TI,AB,KY 119
#16 (follic* adj2 aspirat*):TI,AB,KY 116
#17 (ovum adj2 aspirat*):TI,AB,KY 1
#18 (oocyte* adj2 aspirat*):TI,AB,KY 51
#19 (egg* adj2 aspirat*):TI,AB,KY 1
#20 (egg* adj2 collect*):TI,AB,KY 46
#21 (oocyte* adj2 collect*):TI,AB,KY 147
#22 (ovum adj2 pick?up):TI,AB,KY 13
#23 (egg* adj2 dona*):TI,AB,KY 19
#24 (oocyte* adj2 dona*):TI,AB,KY 178
#25 ((egg* or oocyte*) adj2 donor*):TI,AB,KY 109
#26 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR
#17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 5655
#27 MESH DESCRIPTOR Hypnotics and Sedatives EXPLODE ALL TREES 11857
#28 MESH DESCRIPTOR Conscious Sedation EXPLODE ALL TREES 1264
#29 MESH DESCRIPTOR Narcotics EXPLODE ALL TREES 13262
#30 MESH DESCRIPTOR Fentanyl EXPLODE ALL TREES 4309
#31 MESH DESCRIPTOR Tranquilizing Agents EXPLODE ALL TREES 16765
#32 MESH DESCRIPTOR Anti-Anxiety Agents EXPLODE ALL TREES 9089
#33 (fentanyl or medazepam):TI,AB,KY 10433
#34 (diazepam or midazolam):TI,AB,KY 9829
#35 (propofol or ketamine or isoflurane):TI,AB,KY 13890
#36 MESH DESCRIPTOR Anesthesia and Analgesia EXPLODE ALL TREES 24147
#37 MESH DESCRIPTOR analgesia EXPLODE ALL TREES 6788
#38 MESH DESCRIPTOR acupuncture analgesia EXPLODE ALL TREES 266
#39 MESH DESCRIPTOR Electroacupuncture EXPLODE ALL TREES 632
#40 sedation:TI,AB,KY 11173
#41 (hypnotic* or sedative*):TI,AB,KY 7743
#42 (paracervical block):TI,AB,KY 181
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#43 pethidine:TI,AB,KY 1773
#44 (analgesi* or pain relief ):TI,AB,KY 41195
#45 (electro-acupuncture or electroacupuncture):TI,AB,KY 1432
#46 (anaesthe* or anesthe*):TI,AB,KY 51765
#47 opioid*:TI,AB,KY 13697
#48 alfentanil:TI,AB,KY 1339
#49 (bolus adj2 injection*):TI,AB,KY 2196
#50 #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41
OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR #49 106316
#51 #26 AND #50 191
Appendix 3. MEDLINE search strategy
Searched from 1946 to 9 November 2017
OVID platform
1 Fertilization in Vitro/ or Ovarian Follicle/ or Oocytes/ (84069)
2 exp oocyte donation/ or exp oocyte retrieval/ (3956)
3 (oocyt$ adj5 retriev$).tw. (5466)
4 (oocyt$ adj5 picku$).tw. (103)
5 (egg$ adj5 (retriev$ or picku$)).tw. (350)
6 (IVF or ICSI).tw. (25664)
7 (in vitro adj fertili$).tw. (22958)
8 (intracytoplas$ adj5 sperm).tw. (6718)
9 (egg$ adj2 recover$).tw. (556)
10 (oocyte$ adj2 recover$).tw. (1616)
11 (egg$ adj5 (retriev$ or pick u$)).tw. (357)
12 (oocyt$ adj5 pick u$).tw. (311)
13 (follic$ adj2 aspirat$).tw. (1381)
14 (ovum adj2 aspirat$).tw. (21)
15 (oocyte$ adj aspirat$).tw. (349)
16 (egg$ adj aspirat$).tw. (10)
17 (egg$ adj2 collect$).tw. (1579)
18 (oocyte$ adj2 collect$).tw. (1786)
19 (ovum adj2 pickup).tw. (129)
20 (ovum adj2 pick up$).tw. (453)
21 (egg$ adj2 dona$).tw. (449)
22 ((egg or oocyte$) adj2 donor$).tw. (1491)
23 (oocyte$ adj donat$).tw. (1164)
24 or/1-23 (101891)
25 exp “hypnotics and sedatives”/ or exp alprazolam/ or exp diazepam/ or exp lorazepam/ or medazepam/ or midazolam/ or nitrazepam/
or oxazepam/ (121622)
26 exp Conscious Sedation/ (8465)
27 (hypnotic$ or sedative$).tw. (28508)
28 exp narcotics/ or exp fentanyl/ or exp tranquilizing agents/ or exp anti-anxiety agents/ (322760)
29 (fentanyl or medazepam).tw. (17520)
30 (diazepam or midazolam).tw. (31770)
31 (propofol or ketamine or isoflurane).tw. (44105)
32 exp analgesia/ or exp acupuncture analgesia/ or exp electroacupuncture/ (42138)
33 sedation.tw. (37059)
34 paracervical block.tw. (488)
35 pethidine.tw. (2442)
36 (analgesi$ or pain relief ).tw. (132308)
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37 (electro-acupuncture or electroacupuncture).tw. (4261)
38 (anaesthe$ or anesthe$).tw. (360612)
39 opioid$.tw. (75881)
40 alfentanil.tw. (2272)
41 (bolus adj2 injection$).tw. (12499)
42 or/25-41 (872293)
43 24 and 42 (1669)
44 randomised controlled trial.pt. (498672)
45 controlled clinical trial.pt. (99309)
46 randomized.ab. (435884)
47 placebo.tw. (208814)
48 clinical trials as topic.sh. (195915)
49 randomly.ab. (300285)
50 trial.ti. (196821)
51 (crossover or cross-over or cross over).tw. (81138)
52 or/44-51 (1244419)
53 exp animals/ not humans.sh. (4686392)
54 52 not 53 (1146893)
55 43 and 54 (153)
Appendix 4. Embase search strategy
Searched from 1980 to 9 November 2017
OVID platform
1 exp fertilization in vitro/ (59012)
2 exp ovary follicle/ (108174)
3 exp oocyte donation/ (3781)
4 exp oocyte retrieval/ (5572)
5 (oocyt$ adj5 retriev$).tw. (9089)
6 (oocyt$ adj5 picku$).tw. (160)
7 (egg$ adj5 (retriev$ or picku$)).tw. (739)
8 (IVF or ICSI).tw. (40905)
9 (in vitro adj fertili$).tw. (27451)
10 (intracytoplas$ adj5 sperm).tw. (8845)
11 (egg$ adj2 recover$).tw. (496)
12 (oocyte$ adj2 recover$).tw. (1748)
13 (egg$ adj5 (retriev$ or pick u$)).tw. (745)
14 (follic$ adj2 aspirat$).tw. (1579)
15 (ovum adj2 aspirat$).tw. (24)
16 (oocyte$ adj aspirat$).tw. (398)
17 (egg$ adj aspirat$).tw. (9)
18 (egg$ adj2 collect$).tw. (1881)
19 (oocyte$ adj2 collect$).tw. (2636)
20 (ovum adj2 pickup).tw. (166)
21 (ovum adj2 pick up$).tw. (611)
22 (egg$ adj2 dona$).tw. (907)
23 ((egg or oocyte$) adj2 donor$).tw. (2734)
24 (oocyte$ adj donat$).tw. (1953)
25 or/1-24 (170724)
26 exp sedative agent/ or exp hypnotic sedative agent/ or exp hypnotic agent/ (315612)
27 exp conscious sedation/ (6222)
28 (hypnotic$ or sedati$).tw. (78460)
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29 exp narcotic agent/ (233578)
30 exp FENTANYL/ (54085)
31 exp medazepam/ (876)
32 (diazepam or midazolam).tw. (37567)
33 (propofol or ketamine or isoflurane).tw. (57249)
34 exp tranquilizer/ (368348)
35 exp anxiolytic agent/ (169341)
36 (fentanyl or medazepam).tw. (23574)
37 exp PATIENT CONTROLLED ANALGESIA/ or exp ANALGESIA/ or exp ACUPUNCTURE ANALGESIA/ (139959)
38 sedati$.tw. (67849)
39 paracervical block.tw. (454)
40 pethidine.tw. (2632)
41 (analgesi$ or pain relief ).tw. (170944)
42 (electro-acupuncture or electroacupuncture).tw. (5161)
43 (anaesthe$ or anesthe$).tw. (413171)
44 opioid$.tw. (95217)
45 alfentanil.tw. (2598)
46 (bolus adj2 injection$).tw. (13434)
47 or/26-46 (1248761)
48 25 and 47 (3169)
49 Clinical Trial/ (956884)
50 Randomized Controlled Trial/ (477722)
51 exp randomization/ (76318)
52 Single Blind Procedure/ (30101)
53 Double Blind Procedure/ (142031)
54 Crossover Procedure/ (53857)
55 Placebo/ (302896)
56 Randomi?ed controlled trial$.tw. (170823)
57 Rct.tw. (26275)
58 random allocation.tw. (1713)
59 randomly allocated.tw. (28714)
60 allocated randomly.tw. (2280)
61 (allocated adj2 random).tw. (788)
62 Single blind$.tw. (20075)
63 Double blind$.tw. (177147)
64 ((treble or triple) adj blind$).tw. (730)
65 placebo$.tw. (258758)
66 prospective study/ (414653)
67 or/49-66 (1833790)
68 case study/ (50918)
69 case report.tw. (342376)
70 abstract report/ or letter/ (1016722)
71 or/68-70 (1401761)
72 67 not 71 (1787292)
73 48 and 72 (336)
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Appendix 5. PsycINFO search strategy
Searched from 1806 to 9 November 2017
OVID platform
1 exp Reproductive Technology/ (1656)
2 (oocyt$ adj5 retriev$).tw. (23)
3 (oocyt$ adj5 picku$).tw. (1)
4 (IVF or ICSI).tw. (535)
5 (egg$ adj5 (retriev$ or picku$)).tw. (20)
6 (in vitro adj fertili$).tw. (679)
7 (intracytoplas$ adj5 sperm).tw. (53)
8 (egg$ adj2 recover$).tw. (2)
9 (oocyte$ adj2 recover$).tw. (2)
10 (egg$ or pick u$).tw. (7096)
11 (oocyt$ adj5 pick u$).tw. (1)
12 (follic$ adj2 aspirat$).tw. (0)
13 (ovum adj2 aspirat$).tw. (0)
14 (oocyte$ adj aspirat$).tw. (0)
15 (egg$ adj aspirat$).tw. (0)
16 (egg$ adj2 collect$).tw. (44)
17 (oocyte$ adj2 collect$).tw. (0)
18 (ovum adj2 pickup).tw. (0)
19 (ovum adj2 pick up$).tw. (0)
20 (egg$ adj2 dona$).tw. (116)
21 ((egg or oocyte$) adj2 donor$).tw. (76)
22 (oocyte$ adj donat$).tw. (36)
23 or/1-22 (8889)
24 exp Sedatives/ or exp Tranquilizing Drugs/ or exp Hypnotic Drugs/ (53370)
25 exp Alprazolam/ (690)
26 exp Midazolam/ (469)
27 exp Propofol/ (472)
28 exp Fentanyl/ (417)
29 exp Opiates/ or exp Analgesia/ or exp Narcotic Agonists/ (25591)
30 exp Anesthetic Drugs/ (19650)
31 (hypnotic$ and sedative$).tw. (1352)
32 paracervical block$.tw. (3)
33 pethidine.tw. (80)
34 sedati$.tw. (9203)
35 (analgesi$ or pain relief ).tw. (15783)
36 (electro-acupuncture or electroacupuncture).tw. (312)
37 (anaesthe$ or anesthe$).tw. (14967)
38 opioid$.tw. (19926)
39 alfentanil.tw. (89)
40 (bolus adj2 injection$).tw. (226)
41 or/24-40 (120821)
42 23 and 41 (80)
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Appendix 6. CINAHL search strategy
Searched from 1982 to 9 November 2017
Ebsco platform
# Query Results
S33 S8 AND S32 161
S32 S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR
S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR
S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR
S30 OR S31
198,907
S31 TX bolus N2 injection* 593
S30 TX opioid* 24,706
S29 TX anaesthe* or anesthe* 105,222
S28 TX pethidine 340
S27 TX paracervical block* 56
S26 TX electroacupuncture or TX acupuncture 16,899
S25 (MM “Electroacupuncture”) 830
S24 (MM “Patient-Controlled Analgesia”) 1,146
S23 (MM “Acupuncture Analgesia”) OR (MM “Acupuncture
Anesthesia”) OR (MM “Anesthesia and Analgesia+”)
42,145
S22 TX medazepam or TX lorazepam 981
S21 TX analgesi* 43,331
S20 TX hypnotic* 6,770
S19 (MM “Hypnotics and Sedatives+”) 8,371
S18 (MH “Analgesia”) 5,172
S17 TX (propofol or ketamine or isoflurane) 9,783
S16 TX diazepam or TX midazolam 4,403
S15 TX fentanyl 4,682
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(Continued)
S14 (MH “Alfentanil”) OR TX “alfentanil” 517
S13 TX“bolus injection*” 516
S12 TX“pain relief ” 10,689
S11 (MM “Sedation”) OR TX “sedation” 11,628
S10 (MH “Narcotics+”) OR TX“narcotics” OR (MH “Analgesics,
Opioid+”)
35,974
S9 (MM “Conscious Sedation”) OR TX“Conscious Sedation” 2,912
S8 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 4,291
S7 TX follicle aspiration* 14
S6 (MH “Oocyte Donation”) OR “oocyte donation” 517
S5 TX oocyte collection* 14
S4 TX egg pick up 2
S3 TX oocyte retrieval* 150
S2 TX ICSI 429
S1 (MH “Fertilization in Vitro”) OR “ivf” 3,762
Appendix 7. ClinicalTrials.gov search strategy
Searched 10 January 2017
Web platform
“oocyte recovery AND pain”, “oocyte retrieval AND pain”, “oocyte aspiration AND pain”, “oocyte AND analgesia”, “oocyte AND
analgesic”, “oocyte AND anaesthesia”, “oocyte AND anesthesia”, “oocyte AND sedation”, “oocyte AND acupuncture”, “oocyte AND
block”, “oocyte AND remifentanil”, “oocyte AND fentanyl”, “oocyte AND propofol”, “oocyte AND pethidine”
(150 hits)
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Appendix 8. WHO ICTRP search strategy
Searched 10 December 2016
Web platform
“oocyte recovery AND pain”, “oocyte retrieval AND pain”, “oocyte aspiration AND pain”, “oocyte AND analgesia”, “oocyte AND
analgesic”, “oocyte AND anaesthesia”, “oocyte AND anesthesia”, “oocyte AND sedation”, “oocyte AND acupuncture”, “oocyte AND
block”, “oocyte AND remifentanil”, “oocyte AND fentanyl”, “oocyte AND propofol”, “oocyte AND pethidine”
(48 hits)
Appendix 9. Web of Science search strategy
Searched 12 January 2017
Web platform
“oocyte recovery AND pain”, “oocyte retrieval AND pain”, “oocyte aspiration AND pain”, “oocyte AND analgesia”, “oocyte AND
analgesic”, “oocyte AND anaesthesia”, “oocyte AND anesthesia”, “oocyte AND sedation”, “oocyte AND acupuncture”, “oocyte AND
paracervical block”, “oocyte AND remifentanil”, “oocyte AND fentanyl”, “oocyte AND propofol”, “oocyte AND pethidine”
(329 hits)
Appendix 10. Portal Regional da BVS search strategy
Searched 12 January 2017
Web platform
“oocyte recovery AND pain”, “oocyte retrieval AND pain”, “oocyte aspiration AND pain”, “oocyte AND analgesia”, “oocyte AND
analgesic”, “oocyte AND anaesthesia”, “oocyte AND anesthesia”, “oocyte AND sedation”, “oocyte AND acupuncture”, “oocyte AND
paracervical block”, “oocyte AND remifentanil”, “oocyte AND fentanyl”, “oocyte AND propofol”, “oocyte AND pethidine”
(1007 hits)
Appendix 11. OpenGrey search strategy
Searched 12 January 2017
Web platform
“oocyte recovery AND pain”, “oocyte retrieval AND pain”, “oocyte aspiration AND pain”, “oocyte AND analgesia”, “oocyte AND
analgesic”, “oocyte AND anaesthesia”, “oocyte AND anesthesia”, “oocyte AND sedation”, “oocyte AND acupuncture”, “oocyte AND
block”, “oocyte AND remifentanil”, “oocyte AND fentanyl”, “oocyte AND propofol”, “oocyte AND pethidine”
(0 hits)
WH A T ’ S N E W
Last assessed as up-to-date: 9 November 2017.
Date Event Description
5 February 2018 New citation required but conclusions have not changed The addition of 3 new studies has not led to any change
in the conclusions of this review
5 February 2018 New search has been performed The review has been updated.
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H I S T O R Y
Protocol first published: Issue 3, 2004
Review first published: Issue 3, 2005
Date Event Description
1 November 2012 New search has been performed Review title changed to “Pain relief for women under-
going oocyte retrieval for assisted reproduction”
Following peer review, the primary outcomes have
been changed to intra-operative pain and post-opera-
tive pain, and the secondary outcomes now include live
birth rate
1 November 2012 New citation required and conclusions have changed New studies added with change to conclusions
25 July 2012 New search has been performed New search performed. Nine new RCTs added to the
review: Coskun 2011; Gejervall 2005; Guasch 2005;
Gunaydin 2007; Ma 2008; Meng 2008; Meng 2009;
Ozturk 2006; Sator-Katzenschlager 2006
23 May 2005 Feedback has been incorporated Substantive amendment
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Internal sources
• None, Other.
External sources
• None, Other.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
For the 2012 update, as a result of peer review, review authors amended the objectives of the review to provide a clearer focus. We
reorganised the list of outcomes, with intraoperative and postoperative pain as the primary outcomes, and clinical pregnancy rate as one
of the secondary outcomes. We changed the review title to “Pain relief for women undergoing oocyte retrieval for assisted reproduction.”
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Fertilization in Vitro; Analgesia [∗methods]; Conscious Sedation [∗methods]; Electroacupuncture; Oocyte Retrieval [adverse effects;
∗methods]; Pain Measurement; Pregnancy Outcome; Randomized Controlled Trials as Topic
MeSH check words
Female; Humans; Pregnancy
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